Yoshiya Tanaka
#106,279
Most Influential Person Now
Researcher
Yoshiya Tanaka's AcademicInfluence.com Rankings
Yoshiya Tanakacomputer-science Degrees
Computer Science
#3894
World Rank
#4091
Historical Rank
Computational Linguistics
#277
World Rank
#281
Historical Rank
Machine Learning
#601
World Rank
#608
Historical Rank
Artificial Intelligence
#803
World Rank
#815
Historical Rank
Download Badge
Computer Science
Yoshiya Tanaka's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Yoshiya Tanaka Influential?
(Suggest an Edit or Addition)Yoshiya Tanaka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (2012) (1021)
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus (2019) (936)
- Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011 (2012) (914)
- T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-lβ (1993) (894)
- A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details (2011) (605)
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis (2017) (556)
- Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: twelve-month data from a twenty-four-month phase III randomized radiographic study. (2013) (506)
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus. (2019) (486)
- 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus (2019) (419)
- Janus kinase inhibitors in autoimmune diseases (2013) (335)
- Osteoblasts and osteoclasts in bone remodeling and inflammation. (2005) (330)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial (2018) (325)
- Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials (2017) (283)
- Phase II study of tofacitinib (CP‐690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate (2011) (278)
- Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system (2006) (251)
- Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study) (2017) (227)
- Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions (2016) (214)
- Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus (2013) (204)
- Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study (2019) (189)
- The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells. (2012) (185)
- Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study (2013) (169)
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients (2011) (167)
- The changing landscape of biosimilars in rheumatology (2016) (164)
- Herpes Zoster and Tofacitinib: Clinical Outcomes and the Risk of Concomitant Therapy (2017) (162)
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan (2014) (161)
- Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan (2009) (159)
- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea (2018) (155)
- Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update (2014) (152)
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial (2018) (147)
- Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. (2012) (141)
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II (2015) (139)
- Pneumocystis jiroveci pneumonia in patients with rheumatoid arthritis treated with infliximab: a retrospective review and case-control study of 21 patients. (2009) (138)
- Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety (2011) (134)
- Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: preventive and therapeutic effects on experimental autoimmune encephalomyelitis. (2008) (127)
- Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT) (2014) (126)
- A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus (2007) (126)
- Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis (2009) (123)
- Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study (2015) (122)
- Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study (2011) (120)
- Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions (2012) (120)
- The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells (2013) (119)
- Dopamine released by dendritic cells polarizes Th2 differentiation. (2009) (118)
- Chondrocytes Are Regulated by Cellular Adhesion Through CD44 and Hyaluronic Acid Pathway (1997) (116)
- Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study (2016) (115)
- Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study (2016) (114)
- A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese (2012) (112)
- Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study (2015) (109)
- Advanced glycation end products increase endothelial permeability through the RAGE/Rho signaling pathway (2010) (108)
- Dopamine Induces IL-6–Dependent IL-17 Production via D1-Like Receptor on CD4 Naive T Cells and D1-Like Receptor Antagonist SCH-23390 Inhibits Cartilage Destruction in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model (2011) (105)
- Tocilizumab in patients with adult-onset still’s disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trial (2018) (105)
- Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells. (2010) (104)
- Advanced Glycation End Products Induce Calcification of Vascular Smooth Muscle Cells through RAGE/p38 MAPK (2009) (103)
- Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study (2013) (100)
- Fractalkine, a CX3C‐chemokine, functions predominantly as an adhesion molecule in monocytic cell line THP‐1 (2001) (96)
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients (2012) (94)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (2015) (92)
- A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study (2013) (91)
- Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme (2019) (90)
- Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial (2019) (89)
- Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study) (2016) (88)
- Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. (2005) (88)
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients (2012) (88)
- IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab (2014) (86)
- Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study (2011) (85)
- Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement (2020) (85)
- Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study (2017) (84)
- Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus (2013) (84)
- Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study (2011) (83)
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study) (2010) (82)
- Discontinuation of biologics in patients with rheumatoid arthritis. (2013) (81)
- CD44 Is the Physiological Trigger of Fas Up-Regulation on Rheumatoid Synovial Cells1 (2001) (80)
- Nitric Oxide Synthase Activity in Human Lung Cancer (1997) (80)
- Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. (2006) (79)
- Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan (2019) (78)
- OP0321 Precision medicine using different biological dmards based on characteristic phenotypes of peripheral t helper cells in psoriatic arthritis (2018) (77)
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial (2010) (77)
- Janus Kinase Inhibitor Baricitinib Modulates Human Innate and Adaptive Immune System (2018) (77)
- Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease (2011) (76)
- Hypoxia‐inducible factor‐1α induces cell cycle arrest of endothelial cells (2002) (76)
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis (2011) (76)
- Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach (2022) (75)
- Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3) (2019) (75)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (2007) (75)
- Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study (2017) (74)
- Contribution of the Interleukin‐6/STAT‐3 Signaling Pathway to Chondrogenic Differentiation of Human Mesenchymal Stem Cells (2015) (74)
- Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I (1995) (74)
- Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis (2015) (72)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2) (2008) (72)
- Ligation of CD31 (PECAM-1) on Endothelial Cells Increases Adhesive Function of vβ3 Integrin and Enhances β1 Integrin-Mediated Adhesion of Eosinophils to Endothelial Cells (1999) (71)
- Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis (2016) (71)
- Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial (2021) (71)
- Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. (2004) (70)
- Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody. (2008) (70)
- Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. (2015) (66)
- Time‐dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis (2012) (66)
- Arsenic Trioxide Augments Chk2/p53-mediated Apoptosis by Inhibiting Oncogenic Wip1 Phosphatase* (2008) (65)
- Peripheral Immunophenotyping Identifies Three Subgroups Based on T Cell Heterogeneity in Lupus Patients (2017) (65)
- β1 Integrin/Focal Adhesion Kinase-mediated Signaling Induces Intercellular Adhesion Molecule 1 and Receptor Activator of Nuclear Factor κB Ligand on Osteoblasts and Osteoclast Maturation* (2003) (65)
- Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial (2011) (62)
- Transcriptional regulation of multidrug resistance‐1 gene by interleukin‐2 in lymphocytes (2004) (62)
- Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis (2018) (61)
- Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab (2011) (61)
- Tacrolimus, a Calcineurin Inhibitor, Overcomes Treatment Unresponsiveness Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Arthritis (2010) (61)
- Safety and efficacy of CT-P13 in Japanese patients with rheumatoid arthritis in an extension phase or after switching from infliximab (2017) (60)
- Pterostilbene surpassed resveratrol for anti-inflammatory application: Potency consideration and pharmacokinetics perspective (2014) (60)
- Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. (2003) (60)
- Monocyte chemoattractant protein-1 induces scavenger receptor expression and monocyte differentiation into foam cells. (2003) (60)
- Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial (2014) (60)
- Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study (2019) (59)
- Metabolic Reprogramming Commits Differentiation of Human CD27+IgD+ B Cells to Plasmablasts or CD27−IgD− Cells (2017) (59)
- Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme (2020) (59)
- Intracellular galectin‐9 activates inflammatory cytokines in monocytes (2009) (58)
- Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. (2015) (58)
- Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks (2012) (57)
- Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44. (2003) (57)
- Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production. (2011) (57)
- Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK‐RANKL system (2018) (56)
- JAK inhibitor tofacitinib for treating rheumatoid arthritis: from basic to clinical (2013) (56)
- Next stage of RA treatment: is TNF inhibitor-free remission a possible treatment goal? (2012) (55)
- Cell-to-Cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1alpha,25(OH)2D3, PTH and IL-1alpha-induced osteoclast differentiation and bone resorption. (2002) (54)
- Alendronate Protects Premenopausal Women from Bone Loss and Fracture Associated with High-dose Glucocorticoid Therapy (2008) (54)
- Mast cell-derived tryptase inhibits apoptosis of human rheumatoid synovial fibroblasts via rho-mediated signaling. (2010) (54)
- Autocrine Induction of the Human Pro-IL-1β Gene Promoter by IL-1β in Monocytes (2002) (54)
- Prophylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study (2014) (54)
- Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission (2008) (54)
- Activation of Syk in Peripheral Blood B Cells in Patients With Rheumatoid Arthritis: A Potential Target for Abatacept Therapy (2015) (54)
- Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study (2020) (54)
- State‐of‐the‐art treatment of systemic lupus erythematosus (2020) (53)
- IL-6-accelerated calcification by induction of ROR2 in human adipose tissue-derived mesenchymal stem cells is STAT3 dependent. (2014) (53)
- IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2. (2019) (52)
- Reduced expression of human mismatch repair genes in adult T‐cell leukemia (2005) (52)
- Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway. (2002) (51)
- Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial (2016) (51)
- A functional SNP in EDG2 increases susceptibility to knee osteoarthritis in Japanese. (2008) (51)
- Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial (2014) (51)
- Intensive treatment and treatment holiday of TNF-inhibitors in rheumatoid arthritis (2012) (51)
- Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition. (2018) (51)
- Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry (2015) (50)
- Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease (2018) (50)
- Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules (2012) (50)
- A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease (2017) (48)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J) (2008) (48)
- Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan (2014) (47)
- A Critical Role for Cyclin C in Promotion of the Hematopoietic Cell Cycle by Cooperation with c-Myc (1998) (47)
- RANKL: A therapeutic target for bone destruction in rheumatoid arthritis (2018) (47)
- IL-17 Inhibits Chondrogenic Differentiation of Human Mesenchymal Stem Cells (2013) (47)
- A PRELIMINARY STUDY ON THE INTERFERON-α TREATMENT FOR XEROSTOMIA OF SJÖGREN'S SYNDROME (1993) (46)
- H-Ras/Mitogen-activated Protein Kinase Pathway Inhibits Integrin-mediated Adhesion and Induces Apoptosis in Osteoblasts* (2002) (46)
- Galectin-9 induces osteoblast differentiation through the CD44/Smad signaling pathway. (2010) (46)
- Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis (2018) (46)
- Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold (2016) (45)
- Primary bilateral adrenal intravascular large B-cell lymphoma associated with adrenal failure. (2003) (45)
- Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan (2014) (45)
- Tomosynthesis of the wrist and hand in patients with rheumatoid arthritis: comparison with radiography and MRI. (2014) (45)
- Activation of Wnt5a‐Ror2 signaling associated with epithelial‐to‐mesenchymal transition of tubular epithelial cells during renal fibrosis (2013) (45)
- Stimulation of {beta}1 Integrin Down-Regulates ICAM-1 Expression and ICAM-1-dependent Adhesion of Lung Cancer Cells through Focal Adhesion Kinase (2001) (44)
- Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells (2017) (44)
- Safety, pharmacokinetics, and efficacy of E6011, an antifractalkine monoclonal antibody, in a first-in-patient phase 1/2 study on rheumatoid arthritis (2018) (44)
- Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-Cell leukemia cells (1998) (44)
- Cell-autonomous role of TGFβ and IL-2 receptors in CD4+ and CD8+ inducible regulatory T-cell generation during GVHD. (2012) (44)
- Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study) (2011) (44)
- Expansion of T follicular helper-T helper 1 like cells through epigenetic regulation by signal transducer and activator of transcription factors (2018) (44)
- Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease. (2009) (44)
- Curdlan induces DC-mediated Th17 polarization via Jagged1 activation in human dendritic cells. (2010) (43)
- Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus (2015) (43)
- Role of cyclooxygenase-2 in bone resorption. (2003) (43)
- Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus (2018) (43)
- Autocrine stimulation of interleukin 1α in the growth of adult human T-cell leukemia cells (1989) (43)
- Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis (2016) (42)
- Human mesenchymal stem cells as a tool for joint repair in rheumatoid arthritis. (2015) (42)
- Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication (2010) (42)
- Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. (2006) (42)
- C5a promotes migration, proliferation, and vessel formation in endothelial cells (2010) (41)
- Clinical immunity in bone and joints (2018) (41)
- Pulmonary hemorrhage in patients with systemic lupus erythematosus (1991) (41)
- Crosslinking of CD44 on human osteoblastic cells upregulates ICAM‐1 and VCAM‐1 (2003) (40)
- Imatinib mesylate‐sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: Report of two cases (2004) (40)
- Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study) (2018) (40)
- Macrophage Inflammatory Protein‐1α Induces Hypercalcemia in Adult T‐Cell Leukemia (2004) (40)
- Interaction of Galectin‐9 With Lipid Rafts Induces Osteoblast Proliferation Through the c‐Src/ERK Signaling Pathway (2007) (40)
- Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus (2018) (40)
- Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis (2018) (39)
- Effects of tofacitinib on lymphocytes in rheumatoid arthritis: relation to efficacy and infectious adverse events. (2014) (39)
- Longterm Safety and Efficacy of Subcutaneous Tocilizumab Monotherapy: Results from the 2-year Open-label Extension of the MUSASHI Study (2015) (39)
- High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells. (2003) (39)
- Effectiveness of abatacept for patients with Sjögren’s syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren’s syndrome Endocrinopathy) trial (2016) (39)
- Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (2012) (38)
- D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells. (2013) (38)
- Efficacy and safety of upadacitinib in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE): a placebo-controlled phase IIb/III study (2020) (38)
- β1 integrin–mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas‐mediated apoptosis (2003) (37)
- Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching (2015) (37)
- Clinical practice guideline for Sjögren’s syndrome 2017 (2018) (37)
- Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials (2020) (37)
- Baricitinib Versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis (RA) and an Inadequate Response to Background Methotrexate Therapy: Results of a Phase 3 Study (2015) (37)
- LB0001 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO METHOTREXATE: FINCH1 PRIMARY OUTCOME RESULTS (2019) (37)
- Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro (2014) (37)
- Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study (2013) (37)
- Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes (2013) (37)
- Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial (2007) (36)
- Amplification of IL-21 signalling pathway through Bruton's tyrosine kinase in human B cell activation. (2015) (36)
- Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction (1994) (36)
- Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren's syndrome. (2018) (36)
- Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients (2017) (36)
- Dopamine D2-like receptor signaling suppresses human osteoclastogenesis. (2013) (36)
- Etidronate prevents high dose glucocorticoid induced bone loss in premenopausal individuals with systemic autoimmune diseases. (2004) (36)
- Efficacy and safety of mavrilimumab in Japanese subjects with rheumatoid arthritis: Findings from a Phase IIa study (2015) (36)
- BAFF- and APRIL-targeted therapy in systemic autoimmune diseases (2016) (35)
- Efficacy and safety of baricitinib in Japanese patients with active rheumatoid arthritis: A 52-week, randomized, single-blind, extension study (2018) (35)
- Prednisolone Dosing Regimen for Treatment of Subacute Thyroiditis. (2015) (35)
- Intracellular HMGB1 transactivates the human IL1B gene promoter through association with an Ets transcription factor PU.1 (2007) (34)
- Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin‐2 Through Transcriptional Regulation in Systemic Lupus Erythematosus (2020) (34)
- Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin‐2 Through Transcriptional Regulation in Systemic Lupus Erythematosus (2020) (34)
- Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial—an open-label, one-year, prospective study—Interim analysis of 32 patients for 24 weeks (2014) (34)
- Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial (2014) (34)
- Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. (2002) (34)
- Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors (2012) (33)
- Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy (2015) (33)
- Baricitinib for the treatment of rheumatoid arthritis (2016) (33)
- Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study (2018) (33)
- Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis (2014) (33)
- Why remission is not enough: underlying disease mechanisms in RA that prevent cure (2020) (32)
- Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities (2020) (32)
- Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumab (2015) (32)
- Activation signal transduction by beta1 integrin in T cells from patients with systemic lupus erythematosus. (2007) (31)
- Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation. (2012) (31)
- Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis (2018) (31)
- Engagement of CD44 up-regulates Fas Ligand expression on T cells leading to activation-induced cell death (2006) (31)
- Telmisartan at 80 mg/Day Increases High-Molecular-Weight Adiponectin Levels and Improves Insulin Resistance in Diabetic Patients (2012) (30)
- Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus (2018) (30)
- A rare case of adult-onset nesidioblastosis treated successfully with diazoxide. (2006) (30)
- Validation of different sets of criteria for the diagnosis of Sjögren’s syndrome in Japanese patients (2013) (29)
- Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials (2020) (29)
- Local Delivery of Mesenchymal Stem Cells with Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold Suppress Arthritis in Rats (2014) (29)
- Current concepts in the management of rheumatoid arthritis (2016) (29)
- Treatment strategy based on targeting P-glycoprotein on peripheral lymphocytes in patients with systemic autoimmune disease (2012) (29)
- Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Liver Disease (2016) (29)
- Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials (2018) (29)
- Progress in understanding the safety and efficacy of Janus kinase inhibitors for treatment of rheumatoid arthritis (2016) (29)
- Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity—results from the ENCOURAGE study, a prospective, international, multicenter randomized study (2016) (28)
- Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways (2020) (28)
- Bisphosphonate Induces Remission of Refractory Osteolysis in Langerhans Cell Histiocytosis (2002) (28)
- Evaluation of intestinal microbiotas of healthy Japanese adults and effect of antibiotics using the 16S ribosomal RNA gene based clone library method. (2011) (28)
- [Immunosuppressive mechanisms in diabetes mellitus]. (2008) (28)
- Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis. (2017) (28)
- Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide. (2012) (28)
- Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case–control study of 17 patients (2012) (27)
- 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases (2020) (27)
- Management of symptoms in step‐down therapy of gastroesophageal reflux disease (2005) (27)
- Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study (2016) (26)
- Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update (2019) (26)
- Decrease in Cu Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis (1994) (26)
- Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study (2017) (26)
- The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. (2020) (26)
- Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair (2018) (26)
- Tofacitinib (CP-690,550), an oral janus kinase inhibitor, in combination with methotrexate reduced the progression of structural damage in patients with rheumatoid arthritis: A 24-Month Phase 3 Study (2011) (26)
- Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs—a multicenter, double-blind, parallel-group trial (2011) (26)
- Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial (2017) (26)
- Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan (2019) (26)
- Complete resolution of dermatomyositis with refractory cutaneous vasculitis by intravenous cyclophosphamide pulse therapy. (2008) (25)
- Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus (1989) (25)
- European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance (2021) (25)
- Benign symmetric lipomatosis associated with alcoholism. (2006) (25)
- A rare case of primary hyperparathyroidism with clear cell adenoma. (2004) (25)
- Acquiring Chondrocyte Phenotype from Human Mesenchymal Stem Cells under Inflammatory Conditions (2014) (25)
- IgG4-related disease in the Japanese population: a genome-wide association study (2019) (25)
- OP0020 Validation of new systemic lupus erythematosus classification criteria (2018) (24)
- A multi-biomarker disease activity score tracks clinical response consistently in patients with rheumatoid arthritis treated with different anti-tumor necrosis factor therapies: A retrospective observational study (2015) (24)
- Care for patients with rheumatic diseases during COVID‐19 pandemic: A position statement from APLAR (2020) (24)
- Is it possible to withdraw biologics from therapy in rheumatoid arthritis? (2013) (24)
- Safety and Efficacy of Various Dosages of Ocrelizumab in Japanese Patients with Rheumatoid Arthritis with an Inadequate Response to Methotrexate Therapy: A Placebo-controlled Double-blind Parallel-group Study (2012) (24)
- Disease control by regulation of P-glycoprotein on lymphocytes in patients with rheumatoid arthritis. (2015) (24)
- Macrophage inflammatory protein-1alpha induces hypercalcemia in adult T-cell leukemia. (2004) (24)
- Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study (2022) (24)
- Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome (2016) (23)
- Upadacitinib in Rheumatoid Arthritis: A Benefit–Risk Assessment Across a Phase III Program (2021) (23)
- A review of upadacitinib in rheumatoid arthritis (2020) (23)
- Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study (2020) (23)
- Characterization and Changes of Lymphocyte Subsets in Baricitinib‐Treated Patients With Rheumatoid Arthritis (2018) (23)
- Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2 (2020) (22)
- Stopping tumour necrosis factor-targeted biological DMARDs in rheumatoid arthritis. (2016) (22)
- Heterogeneity of clinical symptoms in patients with familial amyloidotic polyneuropathy (FAP TTR Met30) (1997) (22)
- Rheumatoid arthritis (2020) (22)
- Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trials (2022) (22)
- Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis (2010) (22)
- Methionine Commits Cells to Differentiate Into Plasmablasts Through Epigenetic Regulation of BTB and CNC Homolog 2 by the Methyltransferase EZH2 (2020) (22)
- The JAK inhibitors: do they bring a paradigm shift for the management of rheumatic diseases? (2019) (22)
- Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring. (2018) (22)
- Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy. (2009) (21)
- Factors influencing inter‐day glycemic variability in diabetic outpatients receiving insulin therapy (2016) (21)
- Leflunomide Inhibits PDK1/Akt Pathway and Induces Apoptosis of Human Mast Cells1 (2007) (21)
- Serum brain-derived neurotrophic factor levels as a novel biological marker for the activities of psychiatric symptoms in systemic lupus erythematosus (2010) (21)
- The role of chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis. (2001) (21)
- Fragmented Hyaluronan Induces Transcriptional Up-regulation of the Multidrug Resistance-1 Gene in CD4+ T Cells* (2006) (21)
- B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus. (2017) (21)
- Development of the Asia Pacific Lupus Collaboration cohort (2018) (21)
- The front line of research into immunoglobin G4-related disease - Do autoantibodies cause immunoglobin G4-related disease? (2019) (21)
- Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan (2020) (21)
- The Histone Deacetylase Inhibitors MS-275 and SAHA Suppress the p38 Mitogen-Activated Protein Kinase Signaling Pathway and Chemotaxis in Rheumatoid Arthritic Synovial Fibroblastic E11 Cells (2013) (21)
- Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies (2016) (21)
- Discontinuation of tofacitinib after achieving low disease activity in patients with rheumatoid arthritis: a multicentre, observational study (2017) (20)
- Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study (2018) (20)
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis (2011) (20)
- Glycolaldehyde-modified advanced glycation end-products inhibit differentiation of human monocytes into osteoclasts via upregulation of IL-10. (2019) (20)
- [Pneumocystis carinii pneumonia in patients with connective tissue diseases]. (2002) (20)
- Hepatic sarcoidosis associated with chronic hepatitis C (2002) (20)
- The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis (2019) (20)
- Chemical JAK inhibitors for the treatment of rheumatoid arthritis (2016) (20)
- Iterative decomposition of water and fat with echo asymmetry and least‐squares estimation (IDEAL) of the wrist and finger at 3T: Comparison with chemical shift selective fat suppression images (2013) (20)
- IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion (2018) (20)
- Rationale and design of Diabetes Prevention with active Vitamin D (DPVD): a randomised, double-blind, placebo-controlled study (2016) (19)
- Low levels of 1,5-anhydro-D-glucitol are associated with vascular endothelial dysfunction in type 2 diabetes (2014) (19)
- Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study (2017) (19)
- RANKL as a therapeutic target of rheumatoid arthritis (2020) (19)
- Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years (2021) (19)
- Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus (2017) (19)
- Genome-wide linkage analysis of type 2 diabetes mellitus reconfirms the susceptibility locus on 11p13-p12 in Japanese (2004) (19)
- Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study (2018) (19)
- Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC) (2018) (19)
- Distinctive association of peripheral immune cell phenotypes with capillaroscopic microvascular patterns in systemic sclerosis. (2019) (18)
- Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors (2014) (18)
- No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan (2013) (18)
- Low rates of radiographic progression of structural joint damage over 2 years of baricitinib treatment in patients with rheumatoid arthritis (2019) (18)
- Reduced Progression to Type 2 Diabetes From Impaired Glucose Tolerance After a 2-Day In-Hospital Diabetes Educational Program (2008) (18)
- Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients. (2006) (18)
- Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions (2020) (18)
- A case of multiple brown tumors with primary hyperparathyroidism (2012) (18)
- Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases. (2007) (18)
- Relevance of lymphocyte subsets to B cell‐targeted therapy in systemic lupus erythematosus (2015) (18)
- Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting (2021) (18)
- Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance (2018) (18)
- Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis (2011) (18)
- A randomized, double-blind, parallel-group, phase III study of shortening the dosing interval of subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis and an inadequate response to subcutaneous tocilizumab every other week: Results of the 12-week double-blind period (2018) (17)
- Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis (2011) (17)
- The Asia-Pacific League of Associations for Rheumatology consensus statements on the management of systemic lupus erythematosus (2021) (17)
- Overcoming treatment unresponsiveness mediated by P-glycoprotein overexpression on lymphocytes in refractory active systemic lupus erythematosus (2005) (17)
- Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis (2019) (17)
- THU0167 SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM (2019) (17)
- Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring. (2018) (17)
- Excess Visceral Adipose Tissue Worsens the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus (2016) (17)
- Phenotypic changes of lymphocyte in a patient with IgG4-related disease after corticosteroid therapy (2012) (17)
- OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study) (2013) (17)
- Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial (2015) (17)
- Quantitative susceptibility mapping in patients with systemic lupus erythematosus: detection of abnormalities in normal-appearing basal ganglia (2016) (17)
- Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib (2014) (17)
- Interleukin‐4 induces proliferation of adult T‐cell leukemia cells (1993) (17)
- Intensive Intervention Can Lead to a Treatment Holiday from Biological DMARDs in Patients with Rheumatoid Arthritis (2014) (17)
- Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA) (2020) (17)
- Severe hypercalcemia and hypernatremia associated with calcipotriol for treatment of psoriasis (2003) (17)
- Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study (2020) (17)
- Determinants of Patient’s Global Assessment of Disease Activity and Physician’s Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials (2018) (17)
- Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study (2016) (16)
- Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies (2016) (16)
- Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts (2005) (16)
- Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis (2007) (16)
- Dermal mast cell density in fingers reflects severity of skin sclerosis in systemic sclerosis (2013) (16)
- Attempt to correct abnormal signal transduction in T lymphocytes from systemic lupus erythematosus patients. (2006) (16)
- Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis—a comprehensive review (2021) (16)
- Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head (2017) (16)
- In vitro pharmacological effects of peficitinib on lymphocyte activation: a potential treatment for systemic sclerosis with JAK inhibitors (2019) (16)
- Lymphocyte phenotype and its application to precision medicine in systemic autoimmune diseases✰. (2019) (16)
- Safety, pharmacokinetics, and pharmacodynamics of epratuzumab in Japanese patients with moderate-to-severe systemic lupus erythematosus: Results from a phase 1/2 randomized study (2016) (16)
- Antihypertensive and metabolic effects of high-dose olmesartan and telmisartan in type 2 diabetes patients with hypertension. (2013) (16)
- Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice (2016) (15)
- Filgotinib, a Novel JAK1-Preferential Inhibitor for the Treatment of Rheumatoid Arthritis: An Overview from Clinical Trials. (2021) (15)
- Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia® as Biological Intensive Treatment for RA (ORBIT) study (2014) (15)
- Anti-PD-1 Antibody Therapy Induces Hashimoto's Disease with an Increase in Peripheral Blood Follicular Helper T Cells. (2017) (15)
- Mesial temporal lobe epilepsy as a neuropsychiatric syndrome of systemic lupus erythematosus (2013) (15)
- Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy (2011) (15)
- A case of zoledronate-induced tubulointerstitial nephritis with Fanconi syndrome. (2012) (15)
- Relevance of P-glycoprotein on CXCR4+ B cells to organ manifestation in highly active rheumatoid arthritis (2018) (15)
- Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes (2012) (15)
- Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study (2019) (14)
- Effect of active vitamin D treatment on development of type 2 diabetes: DPVD randomised controlled trial in Japanese population (2022) (14)
- The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database (2014) (14)
- Peficitinib for the treatment of rheumatoid arthritis: an overview from clinical trials (2020) (14)
- Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study (2017) (14)
- Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials (2018) (14)
- Significance of nailfold videocapillaroscopy in patients with idiopathic inflammatory myopathies (2018) (14)
- Induction of expression of MHC‐class‐II antigen on human thyroid carcinoma by wild‐type p53 (1998) (14)
- Diagnosis of early-stage rheumatoid arthritis: usefulness of unenhanced and gadolinium-enhanced MR images at 3 T. (2013) (14)
- Role for adapter proteins in costimulatory signals of CD2 and IL-2 on NK cell activation. (2002) (14)
- Successful treatment of primary biliary cirrhosis with etanercept in a patient with rheumatoid arthritis. (2011) (14)
- Down‐regulation of α6 integrin, an anti‐oncogene product, by functional cooperation of H‐Ras and c‐Myc (2001) (14)
- Assessment of disease activity in rheumatoid arthritis by multi-biomarker disease activity (MBDA) score. (2016) (14)
- A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate (2007) (14)
- Jak inhibitor ; possibility and mechanism as a new disease modifying anti-rheumatic drug. (2009) (14)
- Updated APLAR consensus statements on care for patients with rheumatic diseases during the COVID‐19 pandemic (2021) (14)
- Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients (2018) (13)
- [Type 2 Diabetes and Vascular Endothelial Dysfunction]. (2018) (13)
- Modified- versus immediate-release tofacitinib in Japanese rheumatoid arthritis patients: a randomized, phase III, non-inferiority study (2018) (13)
- Psoriatic arthritis in Japan: difference in clinical features and approach to precision medicine. (2016) (13)
- Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview (2021) (13)
- Incidence of Vitamin D Deficiency and Its Relevance to Bone Metabolism in Japanese Postmenopausal Women with Type 2 Diabetes Mellitus. (2015) (13)
- Systemic Lupus Erythematosus: Targeted Literature Review of the Epidemiology, Current Treatment, and Disease Burden in the Asia Pacific Region (2020) (13)
- Efficacy of α‐glucosidase inhibitors combined with dipeptidyl‐peptidase‐4 inhibitor (alogliptin) for glucose fluctuation in patients with type 2 diabetes mellitus by continuous glucose monitoring (2013) (13)
- Prediction of Femoral Neck Strength in Patients with Diabetes Mellitus with Trabecular Bone Analysis and Tomosynthesis Images. (2016) (13)
- Small GTPase Rho signaling is involved in beta1 integrin-mediated up-regulation of intercellular adhesion molecule 1 and receptor activator of nuclear factor kappaB ligand on osteoblasts and osteoclast maturation. (2007) (13)
- 060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate (2019) (13)
- Safety and efficacy of fostamatinib in rheumatoid arthritis patients with an inadequate response to methotrexate in phase II OSKIRA-ASIA-1 and OSKIRA-ASIA-1X study. (2020) (13)
- l-Leucine influx through Slc7a5 regulates inflammatory responses of human B cells via mammalian target of rapamycin complex 1 signaling (2018) (13)
- Reduced Expression of Platelet Endothelial Cell Adhesion Molecule‐1 in Bone Marrow Cells in Mice After Skeletal Unloading (2005) (13)
- Efficacy of linagliptin and teneligliptin for glycemic control in type 2 diabetic patients with chronic kidney disease: assessment by continuous glucose monitoring; a pilot study (2016) (13)
- Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis (2020) (13)
- A Case of Type 2 Diabetes with a Change from a Non-Dipper to a Dipper Blood Pressure Pattern by Dapagliflozin. (2016) (13)
- Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features. (2006) (13)
- Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies (2015) (13)
- Growth suppression of human mast cells expressing constitutively active c‐kit receptors by JNK inhibitor SP600125 (2006) (13)
- beta1 integrin-mediated signaling induces intercellular adhesion molecule 1 and Fas on rheumatoid synovial cells and Fas-mediated apoptosis. (2003) (13)
- Human dendritic cell-derived osteoclasts with high bone resorption capacity and T cell stimulation ability. (2020) (13)
- Tumour necrosis factor alpha promotes secretion of 14-3-3η by inducing necroptosis in macrophages (2020) (13)
- Low molecular weight hyaluronan increases the Uptaking of oxidized LDL into monocytes. (2007) (13)
- Extrapyramidal symptoms and advanced calcification of the basal ganglia in a patient with autosomal dominant hypocalcemia. (2013) (13)
- Abnormal responses of myeloid progenitor cells to recombinant human colony-stimulating factors in congenital neutropenia (1990) (13)
- Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases (2021) (13)
- Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux (2000) (13)
- Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea (2021) (13)
- Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthyretin (Met‐30) gene (1993) (13)
- Safety and Effectiveness of 6 Months’ Etanercept Monotherapy and Combination Therapy in Japanese Patients with Rheumatoid Arthritis: Effect of Concomitant Disease-modifying Antirheumatic Drugs (2013) (13)
- Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA) (2020) (13)
- Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan (2015) (12)
- Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data (2019) (12)
- THU0202 INTEGRATED SAFETY ANALYSIS OF FILGOTINIB TREATMENT FOR RHEUMATOID ARTHRITIS FROM 7 CLINICAL TRIALS (2020) (12)
- Glucocorticoid-induced osteoporosis: skeletal manifestations of glucocorticoid use and 2004 Japanese Society for Bone and Mineral Research-proposed guidelines for its management (2005) (12)
- First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort (2019) (12)
- Pneumocystisjirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis: a retrospective review of 15 cases and analysis of risk factors (2012) (12)
- A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism. (2002) (12)
- Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE) (2021) (12)
- Histamine inhibits differentiation of skin fibroblasts into myofibroblasts. (2015) (12)
- Safety of baricitinib in East Asian patients with moderate‐to‐severe active rheumatoid arthritis: An integrated analysis from clinical trials (2019) (12)
- Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring (2017) (12)
- Comparison of effects of anagliptin and alogliptin on serum lipid profile in type 2 diabetes mellitus patients (2017) (12)
- Glycated albumin and cross-linking of CD44 induce scavenger receptor expression and uptake of oxidized LDL in human monocytes. (2006) (12)
- SAT0100 Abatacept Biologic-Free Remission Study in Established Rheumatoid Arthritis Patients orion Study (2013) (12)
- Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus (2018) (12)
- Inter- and intracellular signaling in secondary osteoporosis (2003) (12)
- Immunophenotype involved in IgG4-related disease (2019) (11)
- SAT0257 A phase 2b/3 randomised, placebo-controlled, double-blind study of upadacitinib, a selective jak1 inhibitor, in japanese patients with active rheumatoid arthritis and inadequate response to conventional synthetic dmards (2018) (11)
- Clinical Features of Patients with Basedow's Disease and High Serum IgG4 Levels (2017) (11)
- Detrimental effects of high-fat diet loading on vascular endothelial function and therapeutic efficacy of ezetimibe and statins in patients with type 2 diabetes. (2016) (11)
- A case of teriparatide-induced severe hypophosphatemia and hypercalcemia (2014) (11)
- Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study (2011) (11)
- COVID‐19 infection in patients with systemic lupus erythematosus: Data from the Asia Pacific Lupus Collaboration (2020) (11)
- Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review (2020) (11)
- Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study (2014) (11)
- Critical roles of super-enhancers in the pathogenesis of autoimmune diseases (2020) (11)
- Evaluation of adjuvant activities using human antigen presenting cells in vitro. (2008) (11)
- [Drug-induced osteoporosis]. (2007) (11)
- Rheumatoid arthritis: DMARD de-escalation — let the patient guide you (2017) (11)
- Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study (2014) (11)
- B cell or T cell-dominant recurrence after rituximab therapy in patients with SLE (2012) (11)
- Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients. (2018) (11)
- Comparison of efficacy of TNF inhibitors and abatacept in patients with rheumatoid arthritis; Adjusted with propensity score matching. (2018) (11)
- Effect of subcutaneous tocilizumab treatment on work/housework status in biologic-naïve rheumatoid arthritis patients using inverse probability of treatment weighting: FIRST ACT-SC study (2018) (11)
- Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study (2014) (11)
- [Dopamine as an immune-modulator between dendritic cells and T cells and the role of dopamine in the pathogenesis of rheumatoid arthritis]. (2009) (11)
- Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease (2019) (10)
- Constitutive tyrosine and serine phosphorylation of STAT4 in T‐cells transformed with HTLV‐I (2005) (10)
- Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study. (2019) (10)
- Suppressive Activity of Interleukin 4 on the Induction of Antigen‐specific Cytotoxic T Cells in Humans (1991) (10)
- Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial (2018) (10)
- Trans-ancestry genome-wide association study identifies novel genetic mechanisms in rheumatoid arthritis (2021) (10)
- Safety and Effectiveness of Peficitinib (ASP015K) in Patients with Rheumatoid Arthritis: Final Results (32 Months of Mean Peficitinib Treatment) From a Long-Term, Open-Label Extension Study in Japan, Korea, and Taiwan (2021) (10)
- Validity of claims‐based algorithms for selected cancers in Japan: Results from the VALIDATE‐J study (2021) (10)
- Constitutive association of MyD88 to IRAK in HTLV-I-transformed T cells. (2007) (10)
- Efficacy of mizoribine treatment in patients with SjÖgren’s syndrome: an open pilot trial (2003) (10)
- Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial (2019) (10)
- Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry (2020) (10)
- The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan (2021) (9)
- Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry (2021) (9)
- T follicular helper (Tfh) cells in autoimmune diseases. (2016) (9)
- A Study of the Vascular Endothelial Function in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis (2019) (9)
- Erratum: Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (Modern Rheumatology (2007) vol. 17 (28-32) 10.1007/s10165-006-0532-0) (2007) (9)
- Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis (2015) (9)
- Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis (2019) (9)
- Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial (2020) (9)
- Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis with 3 years of treatment: results from a long-term study (2020) (9)
- Role of P-glycoprotein on CD69+CD4+ cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy (2017) (9)
- ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study (2022) (9)
- Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and activators of transcription 3 in lupus patients. (2020) (9)
- [A case of Paragonimiasis westermanii complicated with migrating subcutaneous induration and multiple involvements in the liver]. (2002) (9)
- Long-Term Safety of Tofacitinib up to 9.5 Years: A Comprehensive Integrated Analysis of the RA Clinical Development Program (2018) (9)
- Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data (2019) (9)
- Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome. (2012) (9)
- ‘Not at target’: prevalence and consequences of inadequate disease control in systemic lupus erythematosus—a multinational observational cohort study (2022) (9)
- [Vascular injury by glucocorticoid; involvement of apoptosis of endothelial cells]. (2007) (9)
- Long-term safety and efficacy of weekly subcutaneous tocilizumab monotherapy in patients with rheumatoid arthritis who had an inadequate response to subcutaneous tocilizumab every other week: Results from the open-label extension of the SHINOBI study (2018) (9)
- Evaluation of oxygen extraction fraction in systemic lupus erythematosus patients using quantitative susceptibility mapping (2019) (9)
- Chemokine and Cellular Adhesion in the Context of Heparan Sulfate Proteoglycan (1998) (9)
- Determinants of hemoglobin A1c level in patients with type 2 diabetes after in‐hospital diabetes education: A study based on continuous glucose monitoring (2016) (9)
- Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus. (2019) (8)
- Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study (2012) (8)
- Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat rheumatoid arthritis patients: from the FIRST Registry (2021) (8)
- Clinically relevant radiographic progression in joint destruction in RA patients with abnormal MMP-3 or high levels of CRP despite 1-year treatment with infliximab (2016) (8)
- Iatrogenic osteomalacia: report of two cases. (2013) (8)
- Soluble IL-6R promotes chondrogenic differentiation of mesenchymal stem cells to enhance the repair of articular cartilage defects using a rat model for rheumatoid arthritis. (2019) (8)
- Association of Viral Infection With the Development and Pathogenesis of Systemic Lupus Erythematosus (2022) (8)
- Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study (2020) (8)
- Podocyte and endothelial cell injury lead to nephrotic syndrome in proliferative lupus nephritis (2018) (8)
- Correlation between serological biomarkers of extracellular matrix turnover and lung fibrosis and pulmonary artery hypertension in patients with systemic sclerosis (2020) (8)
- Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis (2020) (8)
- The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus (2020) (8)
- Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells (2020) (8)
- Multi-ancestry genome-wide association analyses identify novel genetic mechanisms in rheumatoid arthritis (2022) (8)
- Assessment of Risks of Pulmonary Infection During 12 Months Following Immunosuppressive Treatment for Active Connective Tissue Diseases: A Large-scale Prospective Cohort Study (2015) (8)
- Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases (2020) (8)
- A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis (2019) (8)
- Involvement of mast cells in systemic sclerosis. (2010) (8)
- Clinical, radiographic and functional efficacy of abatacept in routine care for rheumatoid arthritis patients: Abatacept Leading Trial for RA on Imaging Remission (ALTAIR) study. (2016) (8)
- Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies (2019) (8)
- Is precision medicine possible in rheumatic diseases? Lessons from selective use of targeted therapies in patients with psoriatic arthritis (2020) (8)
- Enhanced Fatty Acid Synthesis Leads to Subset Imbalance and IFN-γ Overproduction in T Helper 1 Cells (2020) (8)
- Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction (2020) (8)
- [Multi-drug resistance in the treatments of autoimmune diseases]. (2006) (8)
- The additive effects of hydroxychloroquine to maintenance therapy with standard of care in patients with systemic lupus erythematosus (2020) (8)
- Twenty‐four‐hour variations in blood glucose level in Japanese type 2 diabetes patients based on continuous glucose monitoring (2017) (7)
- Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the TOWER-GO study (2020) (7)
- [An approach to bone and cartilage repair of rheumatoid arthritis by mesenchymal stem cells]. (2014) (7)
- Human urinary trypsin inhibitor bolus infusion improved severe interstitial pneumonia in mixed connective tissue disease (2005) (7)
- A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study (2012) (7)
- Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study (2022) (7)
- Mechanism of action of baricitinib and identification of biomarkers and key immune pathways in patients with active systemic lupus erythematosus (2022) (7)
- ASP5094, a humanized monoclonal antibody against integrin alpha-9, did not show efficacy in patients with rheumatoid arthritis refractory to methotrexate: results from a phase 2a, randomized, double-blind, placebo-controlled trial (2020) (7)
- Intracranial vessel wall lesions in patients with systematic lupus erythematosus (2018) (7)
- Long-term safety and efficacy of sirukumab for patients with rheumatoid arthritis who previously received sirukumab in randomised controlled trials (SIRROUND-LTE) (2021) (7)
- Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review. (2021) (7)
- Phase II/III Results of a Trial of Anti–Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis (2022) (7)
- Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus (2022) (7)
- Intracranial vessel wall lesions in patients with systematic lupus erythematosus (2018) (7)
- Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Ca (2019) (7)
- A comparison of incidence and risk factors for serious adverse events in rheumatoid arthritis patients with etanercept or adalimumab in Korea and Japan (2014) (7)
- The Effects of Mitiglinide and Repaglinide on Postprandial Hyperglycemia in Patients Undergoing Methylprednisolone Pulse Therapy (2017) (7)
- Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements (2021) (7)
- Efficacy and safety of tabalumab plus standard of care in Japanese patients with active systemic lupus erythematosus: Subgroup analyses of the ILLUMINATE-1 study (2017) (7)
- Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan (2018) (7)
- Fatal Chronic Active Epstein-Barr Virus Infection in a Rheumatoid Arthritis Patient Treated with Abatacept (2018) (7)
- Insensitivity versus poor response to tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective cohort study (2020) (7)
- Suppressive effect of interleukin‐4 on the differentiation of M1 and HL60 myeloid leukemic cells (1993) (7)
- THU0197 SAFETY PROFILE OF UPADACITINIB UP TO 3 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS (2020) (7)
- Effects of Denosumab in Japanese Patients With Rheumatoid Arthritis Treated With Conventional Antirheumatic Drugs: 36-month Extension of a Phase III Study (2021) (7)
- Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera. (2021) (7)
- Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report (2020) (6)
- Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort. (2021) (6)
- Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing (2017) (6)
- Virilizing adrenocortical adenoma with Cushing's syndrome, thyroid papillary carcinoma and hypergastrinemia in a middle-aged woman. (2003) (6)
- Comparative analysis of the effects of alogliptin and vildagliptin on glucose metabolism in type 2 diabetes mellitus. (2017) (6)
- Involvement of lncRNA IL21-AS1 in interleukin-2 and T follicular regulatory cell activation in systemic lupus erythematosus (2021) (6)
- Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases (2021) (6)
- A Randomized, Placebo‐Controlled Phase III Extension Trial of the Long‐Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus (2022) (6)
- Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL) (2022) (6)
- Jak and Syk: Emerging their relevance to the treatment of inflammatory diseases (2011) (6)
- Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120 (2018) (6)
- Involvement of lncRNA IL21-AS1 in interleukin-2 and T follicular regulatory cell activation in systemic lupus erythematosus (2021) (6)
- SAT0257 Clinical and Radiographic Effects after 52-Week of Adding Tocilizumab or Switching to Tocilizumab in RA Patients with Inadequate Response to Methotrexate: Results from A Prospective Randomized Controlled Study (Surprise Study) (2014) (6)
- Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study (2020) (6)
- Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: Normalization by treatment with a proton pump inhibitor (2008) (6)
- 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study (2019) (6)
- Impaired expression of innate immunity-related genes in IgG4-related disease: A possible mechanism in the pathogenesis of IgG4-RD (2020) (6)
- Etidronate for the treatment of progressive tumoral calcinosis in hemodialysis patients. (2007) (6)
- Validity and responsiveness of the Work Functioning Impairment Scale (WFun) in rheumatoid arthritis patients: A multicenter prospective study (2020) (6)
- The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus (2017) (6)
- The role of nailfold videocapillaroscopy in patients with systemic sclerosis (2018) (6)
- A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs (2021) (6)
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept (2012) (6)
- Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. (2014) (6)
- Usefulness of nailfold videocapillaroscopy for systemic sclerosis (2016) (6)
- [Dopamine receptor signaling regulates human osteoclastogenesis]. (2013) (6)
- Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation (2020) (6)
- Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies. (2021) (6)
- Adult‐Onset Idiopathic Progressive Acro‐Osteolysis With Proximal Symphalangism (2003) (6)
- A multi-biomarker disease activity score for monitoring rheumatoid arthritis (2015) (6)
- A pooled safety analysis of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis treated over a median of 2 years (2020) (5)
- [Marked weight loss in two female patients with prader-willi syndrome by behavioral modification and improvement of the environment]. (2006) (5)
- [Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia]. (2005) (5)
- Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders (2020) (5)
- Changes in variant transthyretin levels in patients with familial amyloidotic polyneuropathy (FAP) type i following liver transplantan (1996) (5)
- Type 2 diabetes mellitus complicated by hypertension in Japanese patients: switching treatment from high-dose angiotensin II receptor blockers to losartan plus hydrochlorothiazide. (2014) (5)
- Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study (2021) (5)
- [Involvement of Syk in pathology of systemic autoimmune disease]. (2012) (5)
- Induction of thyroid remission using rituximab in a patient with type 3 autoimmune polyglandular syndrome including Graves' disease and type 1 diabetes mellitus: a case report. (2015) (5)
- B‐B Cell Interactions in the Spontaneous Activation of B Cells in Autoimmune NZB Mice (1991) (5)
- Pancreas-protective effect of rituximab for acute-onset type 1 diabetes in the honeymoon period: a case report (2016) (5)
- Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: Post hoc analysis of the GO-FORTH study (2016) (5)
- Cardiac Autonomic Balance and QT Dispersion During Head‐Up Tilt Testing in Diabetics with and without Sensory Neuropathy (2004) (5)
- [Regulation of osteoclastogenesis by human mesenchymal stem cells leading to application of a novel treatment for rheumatoid arthritis]. (2013) (5)
- A case of blue rubber bleb nevus syndrome treated by etidronate (2007) (5)
- Efficacy and safety of reducing duration of infliximab infusion (2014) (5)
- FRI0333 Effects of Tofacitinib Treatment on Leptin and other Components of the Multi-Biomarker Disease Activity Score in Patients with Rheumatoid Arthritis (2014) (5)
- Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study (2021) (5)
- Apremilast in a Japanese subgroup with Behçet's syndrome: Results from a Phase 3, randomised, double-blind, placebo-controlled study. (2021) (5)
- 1230-P: Addition of Canagliflozin to Insulin Improves Glycemic Control and Reduces Insulin Dose in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring (2019) (5)
- Comparative Efficacy and Safety of Peficitinib Versus Tofacitinib and Baricitinib for Treatment of Rheumatoid Arthritis: A Systematic Review and Network Meta-Analysis (2021) (5)
- Immunological functions and phenotypes of peripheral blood lymphocytes from human T-Cell leukemia virus-I carriers (1989) (5)
- Combination therapy for early rheumatoid arthritis: a treatment holiday perspective (2015) (5)
- Usefulness of the index calculated as the product of levels of fasting plasma glucose and hemoglobin A1c for insulinoma screening. (2020) (5)
- 185 Baricitinib-associated changes in type I interferon gene signature during a 24-week phase 2 clinical SLE trial (2019) (5)
- Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis (2017) (5)
- Intravenous cyclophosphamide pulse therapy is effective for refractory Graves' ophthalmopathy. (2006) (5)
- Successful treatment of osteomalacia caused by renal tubular acidosis associated with Sjögren’s syndrome (2013) (5)
- Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE) (2022) (5)
- Comparison of the Effects of Teneligliptin and Sitagliptin, Two Dipeptidyl Peptidase 4 Inhibitors with Different Half-Lives, on Glucose Fluctuation and Glucagon-Like Peptide-1 in Type 2 Diabetes Mellitus. (2018) (5)
- Case of parathyroid carcinoma with a highly aggressive clinical course. (2014) (5)
- The mutual regulation of arginine-vasopressin and PTHrP secretion in dissociated supraoptic neurons. (2002) (5)
- Baricitinib for systemic lupus erythematosus – Authors' reply (2019) (5)
- An enhanced mitochondrial function through glutamine metabolism in plasmablast differentiation in systemic lupus erythematosus. (2021) (4)
- Mediastinal and axillar lymphadenopathy in patients with rheumatoid arthritis: prevalence and clinical significance. (2019) (4)
- Relationship between glycemic intraday variations evaluated in continuous glucose monitoring and HbA1c variability in type 2 diabetes: pilot study (2021) (4)
- [Tofacitinib for the treatment of rheumatoid arthritis]. (2016) (4)
- An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis (2018) (4)
- Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan (2015) (4)
- Low Vitamin D Levels are Associated with Vascular Endothelial Dysfunction in Patients with Poorly Controlled Type 2 Diabetes: A Retrospective Study (2021) (4)
- [Pathological mechanisms in rheumatoid arthritis]. (2013) (4)
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II) (2023) (4)
- OP0049 EFFICACY OF ANIFROLUMAB IN ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: PATIENT SUBGROUP ANALYSIS OF BICLA RESPONSE IN 2 PHASE 3 TRIALS (2020) (4)
- A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β2 glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies (2012) (4)
- Steroid psychosis in a polyarteritis nodosa patient successfully treated with risperidone: tracking serum brain-derived neurotrophic factor levels longitudinally (2012) (4)
- [Secondary osteoporosis or secondary contributors to bone loss in fracture. The relevance of immune system to bone metabolism]. (2013) (4)
- THU0209 Characterization of Changes in Lymphocyte Subsets in Baricitinib-Treated Patients with Rheumatoid Arthritis in A Phase 3 Study (RA-BEAM) (2016) (4)
- Association Between Diabetic Microangiopathies and Glycemic Variability Assessed by Continuous Glucose Monitoring. (2018) (4)
- Relapsing polychondritis diagnosed by fusion images of gallium-67 on single photon emission computed tomography / computed tomography (2017) (4)
- Five Cases of IgG4-related Disease with Nasal Mucosa and Sinus Involvement (2020) (4)
- [Regulation of inflammation through JAK3-Stat6 pathway in dendritic cells]. (2012) (4)
- Plasma catecholamine metabolite levels and the activities of psychiatric symptoms in systemic lupus erythematosus (2013) (4)
- [A rare case of primary aldosteronism caused by bilateral functioning adrenocortical adenomas with renal cell carcinoma]. (2005) (4)
- Similarity of Response to Biologics Between Elderly-onset Rheumatoid Arthritis (EORA) and Non-EORA Elderly Patients: From the FIRST Registry (2021) (4)
- Lansoprazole-Induced Improvement of Esophageal Submucosal Injury (2007) (4)
- [Biologics: current therapeutic strategies for rheumatoid arthritis]. (2007) (4)
- Multi-trait and cross-population genome-wide association studies across autoimmune and allergic diseases identify shared and distinct genetic component (2022) (4)
- Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study (2018) (4)
- Relapsing polychondritis diagnosed by fusion images of gallium-67 on single photon emission computed tomography / computed tomography (2017) (4)
- [Glucocorticoid and bone metabolism and disease]. (2013) (4)
- OP0149 A Phase 2B Study of an Oral JAK Inhibitor ASP015K Monotherapy in Japanese Patients with Moderate to Severe Rheumatoid Arthritis (2014) (4)
- Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study (2019) (4)
- Analysis of T Cell Stimulation by Superantigen Plus Major Histocompatibility Complex Class II Molecules or by CD 3 Monoclonal Antibody : Costimulation by Purified Adhesion Ligands VCAM-1 , ICAM-1 , but Not ELAM-1 By Gijs (2003) (4)
- Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global Phase 3 study (FINCH 2). (2020) (4)
- Thin-section chest CT findings in polymyalgia rheumatica: a comparison between with and without rheumatoid arthritis. (2016) (4)
- [Inflammatory cytokines for osteoclastogenesis]. (2005) (4)
- Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases (2022) (4)
- POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY (2021) (4)
- Clinical relevance of T follicular helper cells in systemic lupus erythematosus (2021) (4)
- The approach to precision medicine for the treatment of psoriatic arthritis (2020) (4)
- Effects of pravastatin, atorvastatin, and rosuvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia (2013) (4)
- POS0220 INTEGRATED SAFETY PROFILE OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS (2021) (4)
- Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis (2016) (4)
- THU0193 EFFICACY OF TOFACITINIB MONOTHERAPY, TOFACITINIB WITH METHOTREXATE AND ADALIMUMAB WITH METHOTREXATE IN PATIENTS WITH EARLY (≤2 YEARS) VS ESTABLISHED (>2 YEARS) RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF DATA FROM ORAL STRATEGY (2019) (3)
- LB0001 BIMEKIZUMAB IN BDMARD-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE OPTIMAL, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED, ACTIVE REFERENCE STUDY (2022) (3)
- Case of multiple endocrine neoplasia 2B with probable ectopic adrenocorticotropic hormone-secreting liver metastasis from medullary thyroid carcinoma. (2013) (3)
- Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes (2016) (3)
- Patient- and physician-reported outcomes from two phase 3 randomized studies (RAJ3 and RAJ4) of peficitinib (ASP015K) in Asian patients with rheumatoid arthritis (2021) (3)
- A case of rheumatoid arthritis treated with infliximab who developed disseminated Penicillium marneffei infection after visit to Thailand (2017) (3)
- Treatment of Rheumatoid Arthritis after Regression of Lymphoproliferative Disorders in Patients Treated with Methotrexate: A Retrospective, Multi-center Descriptive Study. (2020) (3)
- Skeletal unloading reduces cluster of differentiation (CD) 38 expression in the bone marrow and osteoblasts of mice. (2020) (3)
- Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials (2022) (3)
- AB0469 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients without methotrexate co-administration: Results from the hikari study (2013) (3)
- Effects of phosphorus fertilization on Citrus unshiu MARC. I (1960) (3)
- Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes (2022) (3)
- Blood glucose dynamics during sleep in patients with obstructive sleep apnea and normal glucose tolerance: effects of CPAP therapy (2021) (3)
- Clinical Profiles and Outcomes of End-Stage Renal Failure Patients with Late Initiation of Renal Replacement Therapy Based on Uremic Symptoms under Intensive Renoprotective Therapies (2002) (3)
- SAT0207 Comparison of Efficacies of Abatacept and Tocilizumab in Patients with Rheumatoid Arthritis by a Propensity-Score Matching (2015) (3)
- Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study (2020) (3)
- AB0468 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients with an inadequate response to methotrexate: Results from the jrapid study (2013) (3)
- FRI0176 Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite dmard therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments (2013) (3)
- SAT0186 Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csdmards: results from the 12-month double blind phase 3, desirable study (2017) (3)
- A case of systemic lupus erythematosus with marked ascites due to idiopathic non-cirrhotic portal hypertension (2021) (3)
- Adenosine downregulates cytokine‐induced expression of intercellular adhesion molecule‐1 on rheumatoid synovial fibroblasts independently of adenosine receptor signaling (2003) (3)
- AJAK inhibitor, tofacitinibreduces IL-6 and matrix metalloproteinase-3 productionin rheumatoid arthritis with suppressed cartilage destruction (2012) (3)
- Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study (2022) (3)
- [Efficacy of anti-cytokines and anti-RANKL antibody for treatment of RA and osteoporosis]. (2007) (3)
- [Glucocorticoid and Bone. Pathogenesis of glucocorticoid-induced osteoporosis]. (2014) (3)
- FRI0132 A multi-biomarker disease activity score (the vectra DA algorithm score) reflects clinical remission for rheumatoid arthritis (RA) in the best study (2013) (3)
- [Recent progress in neuropsychiatric systemic lupus erythematosus]. (2013) (3)
- OP0223 EFFICACY AND SAFETY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (3)
- Potential of B-cell-targeting therapy in overcoming multidrug resistance and tissue invasiveness associated with P-glycoprotein expressing-B cell compartments (2020) (3)
- [Vascular Calcification - Pathological Mechanism and Clinical Application - . Bisphosphonates for vascular calcification]. (2015) (3)
- FRI0177 52-week results of clinical, radiographic and pharmacokinetic assessments: Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy (2013) (3)
- Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis. (2021) (3)
- IL-6/STAT3 pathway is critically involved in vascular calcification via histone modification of the RUNX2 promoter in vascular smooth muscle cells (2016) (3)
- [JAK inhibitor]. (2013) (3)
- Enlarged glycemic variability in sulfonylurea-treated well-controlled type 2 diabetics identified using continuous glucose monitoring (2021) (3)
- LYSOSOMES AND LYMPHOCYTE RESPONSE (1965) (3)
- Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes (2022) (3)
- Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study (2020) (3)
- Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) (2016) (3)
- Response to tocilizumab and work productivity in patients with rheumatoid arthritis: 2-year follow-up of FIRST ACT-SC study (2020) (3)
- Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes (2022) (3)
- Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 study (2018) (3)
- POS0691 EFFECTS OF ANIFROLUMAB ON RENAL DISEASE IN PATIENTS WITH SLE (2021) (3)
- Pathological role of activated mTOR in CXCR3+ memory B cells of rheumatoid arthritis. (2021) (3)
- Optimal Biologic Selection for Treatment of Psoriatic Arthritis: the Approach to Precision Medicine (2019) (3)
- [Remission induction of refractory diffuse large B-cell lymphoma with allogeneic peripheral blood stem cell transplantation followed by interferon-alpha and donor lymphocyte infusion]. (2004) (3)
- Two Sisters with Graves' Disease and Similar Clinical Features who Tested Positive for Anti-insulin Antibodies after Thiamazole Treatment. (2016) (3)
- Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study (2022) (3)
- Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease (2022) (3)
- FRI0236 Safety, Pharmacokinetics and Efficacy of E6011, An Anti-Fractalkine Monoclonal Antibody, in A First-in-Patient Phase 1/2 Study in Rheumatoid Arthritis (2016) (3)
- Effect of bimekizumab on symptoms and impact of disease in patients with psoriatic arthritis over 3 years: results from BE ACTIVE (2022) (3)
- [A case of rheumatoid arthritis with secondary amyloidosis in urinary bladder]. (2002) (3)
- The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method (2020) (3)
- Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T) (2019) (3)
- Radiological patterns of pulmonary involvement may predict treatment response in rheumatoid arthritis: A retrospective study. (2019) (3)
- Efficacy and safety of anti-TNF multivalent NANOBODY® compound 'ozoralizumab' without methotrexate co-administration in patients with active rheumatoid arthritis: A 52-week result of phase III, randomised, open-label trial (NATSUZORA trial). (2022) (3)
- [The importance of B cell-T cell interaction in autoimmune diseases]. (2015) (2)
- Hypoglycemia in blood glucose level in type 2 diabetic Japanese patients by continuous glucose monitoring (2019) (2)
- FRI0128 FILGOTINIB PROVIDED RAPID AND SUSTAINED IMPROVEMENTS IN FUNCTIONAL STATUS, PAIN, HEALTH-RELATED QUALITY OF LIFE, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: RESULTS FROM THE FINCH 1 STUDY (2020) (2)
- [Successful treatment of intravenous cyclophosphamide pulse therapy for lupus myelitis with urinary disturbance and acute confusional state]. (2004) (2)
- Juvenile-onset hereditary pheochromocytoma-paraganglioma syndrome. (2013) (2)
- [Successful treatment of intravenous cyclophosphamide pulse therapy for systemic lupus erythematosus complicated with steroid-resistant hemolytic anemia]. (2003) (2)
- Treatment with Methotrexate and Intravenous Cyclophosphamide Pulse Therapy Regulates the P-gp+CD4+ Cell-related Pathogenesis in a Representative Patient with Refractory Proliferative Lupus Nephritis (2019) (2)
- Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis (2020) (2)
- Efficacy of Intravenous Cyclophosphamide Pulse Therapy for P-Glycoprotein-expressing B Cell-associated Active True Renal Lupus Vasculitis in Lupus Nephritis (2017) (2)
- A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β2 glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies (2012) (2)
- THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7,901 patients in japan (2013) (2)
- A Case of Marine-Lenhart Syndrome with Predominance of Plummer Disease. (2019) (2)
- [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases]. (2009) (2)
- A phase 2a, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the oral gonadotropin-releasing hormone antagonist, ASP1707, in postmenopausal female patients with rheumatoid arthritis taking methotrexate (2020) (2)
- Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosus (2022) (2)
- [Diabetes mellitus and osteoporosis. Mutual interaction between bone and blood vessel in diabetes mellitus]. (2012) (2)
- 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study (2019) (2)
- [Secondary osteoporosis UPDATE. Rheumatoid arthritis and bone damage: trends in treatment]. (2010) (2)
- P-glycoprotein Expressing-B cell associated Active True Renal Lupus Vasculitis in Lupus Nephritis (2020) (2)
- Difficult-to-treat rheumatoid arthritis with respect to responsiveness to biologic/targeted synthetic DMARDs: a retrospective cohort study from the FIRST registry. (2021) (2)
- [Mesenchymal stem cells for the treatment and repair of inflammatory arthritis]. (2015) (2)
- Small Cell Lung Cancer Patient with Anti-transcriptional Intermediary Factor 1γ Antibody Who Developed Dermatomyositis after Successful Chemoradiotherapy (2018) (2)
- Dawn of Precision Medicine in Psoriatic Arthritis (2022) (2)
- Changes in endothelial function during educational hospitalization and the contributor to improvement of endothelial function in type 2 diabetes mellitus (2020) (2)
- Relapsing Polychondritis Diagnosed by Fusion Images of Gallium‐67 Uptake on Computed Tomography and Single‐Photon–Emission Computed Tomography (2017) (2)
- Cd31 pecam 1 is an adhesion amplifier on unique t cell subsets (1992) (2)
- [Primary hyperparathyroidism complicated with flail chest due to severe osteoporosis]. (2006) (2)
- [Anti-RANKL antibody for the treatment of rheumatoid arthritis]. (2011) (2)
- Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus (2019) (2)
- Anti‐CD20 and other novel biotherapies for systemic lupus erythematosus (2006) (2)
- Rapidly progressive glomerulonephritis after introduction of certolizumab pegol: a case report (2020) (2)
- P210 Efficacy and safety of filgotinib for patients with RA with inadequate response to methotrexate: FINCH1 primary outcome results (2020) (2)
- Janus kinase (JAK) inhibitors in rheumatoid arthritis (2011) (2)
- [Rheumatoid arthritis and osteoporosis: trends in their treatments]. (2006) (2)
- Response to: ‘Some concerns from Turkey’ by Bilgin et al (2018) (2)
- [New assessment method in rheumatoid arthritis]. (2016) (2)
- Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease (2022) (2)
- Successful Management of Pregnancy in a Patient with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension (2018) (2)
- Title: Post-Marketing Surveillance of the Safety Profile of Infliximab in 5,000 Japanese Patients with Rheumatoid Arthritis (2007) (2)
- Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis (2021) (2)
- OP0045 DELINEATION OF A PROINFLAMMATORY CYTOKINE PROFILE TARGETED BY JAK1/2 INHIBITION USING BARICITINIB IN A PHASE 2 SLE TRIAL (2020) (2)
- Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study (2022) (2)
- [Bisphosphonates for vascular calcification]. (2007) (2)
- Regulatory Mechanism of The Induction of Regulatory T Cells through Growth Factors Released by Human Mesenchymal Stem Cells. (2018) (2)
- IgG4-type Multiple Myeloma with Diffuse Enlargement of the Thyroid Requiring Differentiation from IgG4-related Disease (2020) (2)
- Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3). (2021) (2)
- Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study (2022) (2)
- Erratum: Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (Modern Rheumatology DOI: 10.1007/s10165-011-0586-5) (2012) (2)
- Microarray Pathway Analysis Comparing Baricitinib and Adalimumab in Moderate to Severe Rheumatoid Arthritis Patients, from a Phase 3 Study (2017) (2)
- Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort (2022) (2)
- Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study (2022) (2)
- JAK inhibitor: tofacitinib, a new disease modifying anti-rheumatic drug (2011) (2)
- Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study (2022) (2)
- Relapsing Polychondritis Diagnosed by Fusion Images of Gallium‐67 Uptake on Computed Tomography and Single‐Photon–Emission Computed Tomography (2017) (2)
- [Paradigm shift in the treatment of rheumatoid arthritis by biologics]. (2008) (2)
- THU0031 Baseline Characteristics and Treatment Outcomes of Patients Who Achieve Deep Remission in Rheumatoid Arthritis (2016) (2)
- Immunogenicity of sarilumab and impact on safety and efficacy in Japanese patients with rheumatoid arthritis: analysis of two Phase 3 randomised clinical trials. (2021) (2)
- OP0154 Integrated Safety Analysis of Tofacitinib in RA Clinical Trials with A Cumulative Exposure of 12,664 Patient-Years (2014) (2)
- THU0190 Better Clinical Responses Seen Early with the Loading Dose of Certolizumab Pegol are Maintained until One Year (2014) (2)
- The Efficacy and Safety of Anifrolumab in Japanese Patients With Systemic Lupus Erythematosus: TULIP-2 Subanalysis. (2022) (2)
- [Anti-rheumatic effect of JAK-inhibitors]. (2012) (2)
- SAT0126 A PHASE 2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS INADEQUATELY RESPONDING TO BIOLOGICS (2019) (2)
- INTERCELLULAR ADHESION MOLECULE 1 UNDERLIES THE FUNCTIONAL HETEROGENEITY OF SYNOVIAL CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS (2000) (2)
- FRI0205 Golimumab administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy: long-term clinical, radiographic and safety results, including evaluation of remission using the new acr/eular criteria (2013) (2)
- CD 44 Stimulation Induces Integrin-mediated Adhesion of Colon Cancer Cell Lines to Endothelial Cells by Up-Regulation of Integrins and c-Met and Activation of Integrins 1 (1999) (2)
- A wide perspective of targeted therapies for precision medicine in autoimmune diseases (2020) (2)
- A case of eosinophilic granulomatosis with polyangiitis as a mimicker of IgG4-related disease (2020) (2)
- Efficacy and safety of the anti-TNF multivalent NANOBODY® compound ozoralizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: A 52-week result of a phase II/III study (OHZORA trial). (2022) (2)
- Systemic lupus erythematosus: prediction by MRI of the subsequent development of brain lesions. (2014) (2)
- No association between BDNF Val66Met polymorphism and emergence of psychiatric symptoms in systemic lupus erythematosus patients (2011) (2)
- A Patient with Eosinophilic Granulomatosis with Polyangiitis Successfully Weaned from Corticosteroids Through Remission Induction Therapy with Mepolizumab. (2022) (2)
- Associations of improvement in laboratory tests with clinical outcomes in patients with active systemic lupus erythematosus: a multinational longitudinal cohort study (2022) (2)
- AB0291D PREDICTORS OF NEW BONE EROSION IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING CSDMARDS: ANALYSIS OF DATA FROM THE DRIVE AND DESIRABLE STUDIES (2019) (2)
- Addition of canagliflozin to insulin improves glycaemic control and reduces insulin dose in patients with type 2 diabetes mellitus: A randomized controlled trial (2019) (2)
- Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan (2019) (2)
- Glucose-lowering effects of 7-day treatment with SGLT2 inhibitor confirmed by intermittently scanned continuous glucose monitoring in outpatients with type 1 diabetes. A pilot study. (2020) (2)
- Correction to: Temporary interruption of baricitinib: characterization of interruptions and effect on clinical outcomes in patients with rheumatoid arthritis (2020) (2)
- Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). (2021) (2)
- Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND (2021) (2)
- The non-canonical Wnt5a/Ror2 signaling pathway in bone metabolism (2014) (2)
- Rheumatoid arthritis (2020) (2)
- [Mutual interaction between vitamin D and lifestyle-related diseases in women]. (2012) (2)
- SAT0131 Continuation/discontinuation of methotrexate and clinical response to etanercept determine the radiographic progression/repair in patients with rheumatoid arthritis: A subanalysis of 52-week results from the JESMR study (2013) (1)
- 247 The efficacy of anti-cd20 antibody rituximab for refractory patients with systemic lupus erythematosus (2017) (1)
- Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study (2022) (1)
- Mild Encephalitis/Encephalopathy with Reversible Splenial Lesions in SLE (2020) (1)
- mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors. (2021) (1)
- IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis (2022) (1)
- Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes (2020) (1)
- Novel development of collagen disease rheumatism medical care. IV. Latest topics. 2. New treatment of the systemic lupus erythematosus. (2005) (1)
- Mesenchymal stem cells: A new treatment tool for rheumatoid arthritis (2012) (1)
- Stimulation of be-ta1 integrin down-regulates ICAM-1 expression and ICAM-1 dependent adhesion of lung cancer cells through focal adhesion kinase (2000) (1)
- Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis (2020) (1)
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis (2011) (1)
- THU0102 PATIENT DISEASE TRAJECTORIES IN BARICITINIB-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE (2019) (1)
- THU0212 BARICITINIB-ASSOCIATED CHANGES IN GLOBAL GENE EXPRESSION DURING A 24-WEEK PHASE 2 CLINICAL SLE TRIAL DESCRIBE A MECHANISM OF ACTION THROUGH INHIBITION OF JAK/STAT AND IFN RESPONSIVE GENE EXPRESSION (2019) (1)
- Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study (2021) (1)
- Focal Eosinophilic Myositis (2019) (1)
- P209 Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the select Phase 3 clinical programme (2020) (1)
- [New biologic and non biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis]. (2009) (1)
- The possible mode of action of Tofacitinib, a JAK inhibitor (2014) (1)
- [Clinical implication of cyclosporin for rheumatoid arthritis]. (2002) (1)
- An autopsy case of a patient with systemic sclerosis who developed marked pulmonary hypertension because of pulmonary tumor thrombotic microangiopathy caused by gastric carcinoma (2020) (1)
- A Case of Type 2 Diabetes Mellitus with NASH Successfully Treated Using Integrated Therapy Including Ipragliflozin (2015) (1)
- Denosumab for the treatment of joint and bone diseases (2011) (1)
- [Diagnosis and therapy for systemic lupus erythematosus]. (2007) (1)
- Systemic lupus erythematosus with repeated protein-losing enteropathy resulting from different pathological conditions: a case report (2020) (1)
- Regulatory role of mesenchymal stem cells in osteoclast differentiation (2013) (1)
- [Imaging assessment of bone and cartilage destruction in rheumatoid arthritis]. (2015) (1)
- Pericarditis induced by prophylactic administration of isoniazid in a patient with rheumatoid arthritis. (2011) (1)
- Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis (2021) (1)
- [Abnormal expression of chemokine receptor on B cells in patients with SLE]. (2015) (1)
- Efficacy and Safety of Switching from Adalimumab to Baricitinib: Phase 3 Data in Patients with Rheumatoid Arthritis (2016) (1)
- POS0221 COMPARISON OF TOFACITINIB AND BARICITINIB BY INVERSE PROBABILITY OF TREATMENT WEIGHTING ANALYSES BASED ON PROPENSITY SCORE IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL CLINICAL PRACTICE (2021) (1)
- [Cytokines in bone diseases. Anti-cytokine therapies for bone and joint diseases]. (2010) (1)
- [Recent progress in clinical trials for rheumatic diseases]. (2009) (1)
- [Anti-RANKL antibody for the treatment of bone and cartilage destruction in rheumatoid arthritis]. (2015) (1)
- Long-Term Safety and Efficacy of Belimumab in Japanese Patients with SLE: a 7-Year Open-Label Continuation Study. (2021) (1)
- FRI0165 PATIENT- AND PHYSICIAN-REPORTED OUTCOMES FROM RAJ4: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE (MTX) (2019) (1)
- [Erythropoietin resistant anemia and neutropenia due to copper deficiency during long-term enteral nutrition on maintained hemodialysis]. (2007) (1)
- Abatacept inhibits radiographic progression in patients with rheumatoid arthritis: a retrospective analysis of 6 months of abatacept treatment in routine clinical practice. The ALTAIR study (2013) (1)
- Achieving drug-free remission: elucidating the role of TNF in rheumatoid arthritis (2010) (1)
- SOD2 mRNA as a potential biomarker for exercise: interventional and cross-sectional research in healthy subjects (2021) (1)
- [A Case of Thyroid Dysfunction and Isolated Adrenocorticotropin Deficiency after Nivolumab Therapy for Malignant Melanoma]. (2021) (1)
- A new and sensitive tool for autonomic dysfunction: Analysis by radiolabelled meta-iodobenzylguanidine (MIBG) in patients with familial amyloidotic polyneuropathy (FAP) (1995) (1)
- [Corticosteroids for treatment of rheumatoid arthritis]. (2005) (1)
- [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder]. (2012) (1)
- Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study (2020) (1)
- [Prophylaxis of glucocorticoid-induced osteoporosis]. (2006) (1)
- A Case of Resistance to Thyroid Hormone (RTH) with a Negative Family History with Diagnosis Based on Persistent Palpitations. (2016) (1)
- Kdm5a promotes B cell activation in systemic lupus erythematosus via downregulation of A20 by histone modification. (2021) (1)
- [Chemokines in health and diseases]. (2002) (1)
- Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study (2021) (1)
- A Japanese Patient with Anti-PM/Scl and Centromere Antibody-Positive Scleroderma-Amyopathic Dermatomyositis Overlap Syndrome Who Developed Renal Crisis. (2021) (1)
- [Clinical implication of cyclosporin for systemic autoimmune diseases: relevance to multidrug resistance]. (2002) (1)
- Mild Encephalitis/Encephalopathy with Reversible Splenial Lesions in SLE (2020) (1)
- Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus (2021) (1)
- EP1.04-26 Efficacy and Safety of Anti-PD-1 Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer (2019) (1)
- [Apathetic hyperthyroidism with heart failure in an elderly patient with Plummer's disease]. (2014) (1)
- [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Anti-bone resorbing treatment for rheumatoid arthritis.] (2018) (1)
- mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitors. (2021) (1)
- Clinical Features of Behçet's Disease Patients with Joint Symptoms in Japan: A National Multicenter Study. (2021) (1)
- AB0416 A COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF YLB113 AND ETANERCEPT REFERENCE PRODUCT FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (2019) (1)
- Correlations Between Glycemic Parameters Obtained from Continuous Glucose Monitoring and Hemoglobin A1c and Glycoalbumin Levels in Type 2 Diabetes Mellitus. (2020) (1)
- cDNA Cloning of Inducer Reactive Protein in Adult T-Cell Leukemia Cells by Applying the Fuzzy Set Cloning Theory for Sequencing Defuzzification (1999) (1)
- A case of bone destruction caused by chronic non-bacterial osteomyelitis (CNO) successfully repaired with a tumour necrosis factor-α (TNF-α) inhibitor, adalimumab (2020) (1)
- [Recent topics on new biological agents for treatment of rheumatoid arthritis]. (2008) (1)
- Therapeutic perspectives on the metabolism of lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus (2021) (1)
- [Positioning of bisphosphonates for vascular calcification]. (2010) (1)
- POS0670 ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH LONG-TERM UPADACITINIB THERAPY (2021) (1)
- P597 Pooled safety analyses from Phase 3 studies of filgotinib in patients with rheumatoid arthritis (2020) (1)
- A case of systemic lupus erythematosus in which Cushing’s syndrome caused by adrenal adenoma accidentally occurred during long-term maintenance therapy with corticosteroids (2020) (1)
- [A case of hypothyroidism due to hashimoto disease that presented elevations of free T3 and free T4 by thyroid hormone autoantibodies]. (2002) (1)
- [Opportunistic infections in patients with collagen disease]. (2004) (1)
- [Anti-CD20 antibody therapy for inflammatory immune diseases]. (2006) (1)
- [Biologic agents for the treatment of rheumatic diseases]. (2014) (1)
- Work Environment-related Stress Factors are Correlated with Diabetes Development in Workers with Impaired Glucose Tolerance: A 5-year Follow-up Study Using the Brief Job Stress Questionnaire (BJSQ). (2021) (1)
- Short-term effectiveness of ixekizumab to refractory psoriatic arthritis with spondyloarthritis: two case reports (2020) (1)
- Scleroderma in an ice-cream shop worker. (2018) (1)
- Changed affinity of apolipoprotein al to high density lipopotein (HDL) in patients with familial amyloidotic polyneuropathy (FAP) (Met30, Gln89, Pro36, Thr34) (1996) (1)
- Efficacy and Safety of Tofogliflozin on 24-H Glucose Profile Based on Continuous Glucose Monitoring: Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor. (2019) (1)
- THU0057B TNF-ALPHA INDUCES NECROPTOSIS-LIKE DEATH OF MACROPHAGES AND PROMOTES EXTRACELLULAR RELEASE OF 14–3–3ETA (2019) (1)
- SAT0622 Multicenter 14-3-3ETA biomarker reproducibility; the japanese experience (2017) (1)
- Clinical images: Takayasu arteritis diagnosed by positron emission tomography. (2007) (1)
- Relationship between interstitial glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics; a pilot study (2020) (1)
- Design characteristics of the Corrona Japan rheumatoid arthritis registry (2018) (1)
- THU0095 IMPACT OF BASELINE EROSION SCORE ON RESPONSE TO TREATMENT AND FUTURE RADIOLOGICAL DAMAGE IN AVERT-2, A RANDOMISED PHASE IIIB STUDY OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY–POSITIVE (ACPA+) PATIENTS WITH EARLY RA (2020) (1)
- Fatal hemoperitoneum due to rupture of mesenteric artery in remission state of microscopic polyangiitis, concomitant with severe hypertension and posterior reversible encephalopathy syndrome: an autopsy case report (2021) (1)
- The two cases of acute acalculous cholecystitis associated with systemic lupus erythematosus (SLE) presented different clinical aspects (2019) (1)
- POS0683 NOVEL STRINGENT OUTCOME MEASURES APPLIED TO THE PHASE 2 AND 3 ANIFROLUMAB TRIALS (2021) (1)
- [A case of Hypothyroid Graves' disease with extremely high titers of TSAb]. (2003) (1)
- [Systemic lupus erythematosus]. (2023) (1)
- [Recent progress in the treatment of rheumatoid arthritis]. (2012) (1)
- FRI0156 A PHASE 1, SINGLE AND MULTIPLE ASCENDING DOSE STUDY OF TAS5315—A NOVEL HIGHLY SELECTIVE INHIBITOR OF BRUTON’S TYROSINE KINASE—IN HEALTHY MALE VOLUNTEERS (2019) (1)
- Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al. (2016) (1)
- Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous glucose monitoring: Results from a prospective observational study. (2022) (1)
- Letters to the editor (1993) (1)
- Two patients with mixed connective tissue disease complicated by pulmonary arterial hypertension showing contrasting responses to pulmonary vasodilators (2020) (1)
- FRI0124 Temporary interruptions of study drug during the baricitinib phase 3 rheumatoid arthritis program (2017) (1)
- Response of thyrotropin-secreting pituitary tumors to preoperative lanreotide therapy. Report of two cases. (2020) (1)
- Efficacy and safety of abatacept in biologic-naïve patients with active rheumatoid arthritis by background methotrexate dose: post hoc analysis of a randomized, placebo-controlled, phase 4 study. (2021) (1)
- [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis]. (2007) (1)
- Synovial Cells UpRegulates VCAM-1 Cross-Linking of CD 44 on Rheumatoid (1999) (1)
- [Secondary osteoporosis. Bone metabolic disorder in Rheumatoid arthritis.] (2018) (1)
- 1. Systemic Lupus Erythematosus (2007) (1)
- Problems Related to the Treatment of Working Diabetic Patients (2005) (1)
- Secondary adrenocortical insufficiency complicated by marked hypercalcemia and eosinophilia: a case report. (2015) (1)
- Efficacy and safety of switching from adalimumab to baricitinib: long-term data from phase 3 extension study in patients with rheumatoid arthritis (2018) (1)
- FRI0110 The impact of seropositivity on the effectiveness of abatacept versus tnf inhibitors in rheumatoid arthritis. real life data from several european registries (THE PAN-ABA STUDY) (2018) (1)
- 247 The efficacy of anti-cd20 antibody rituximab for refractory patients with systemic lupus erythematosus (2017) (1)
- AB0435 Effects of Prior Use of BIOLOGICS on the Safety and Effectiveness of Abatacept Administered with or without Methotrexate in Japanese Patients with Rheumatoid Arthritis: Sub-Analysis of the Abatacept All-Cases Post-Marketing Surveillance (2014) (1)
- FRI0474 The Three-Year Outcome of Infliximab (IFX), an Anti-TNF-α Antibody, in Patients with Refractory Intestinal-BehÇEt's Disease (BD) (2014) (1)
- Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long‐Term Clinical Outcomes: A Five‐Year Prospective Study (2022) (1)
- Sustained Remission and Outcomes with Abatacept plus Methotrexate Following Stepwise Dose De-escalation in Patients with Early Rheumatoid Arthritis (2023) (1)
- SAT0140 Effectiveness of Abatacept Against Rheumatoid Arthritis in Daily Clinical Practice - Orbit Study (2013) (1)
- Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements (2022) (1)
- THU0149 Efficacy and Safety of Baricitinib in Japanese Rheumatoid Arthritis Patients at 12 Weeks (2014) (1)
- Efficacy and safety of anti-CD 20 antibody rituximab for patients with refractory systemic lupus erythematosus (2018) (1)
- FRI0087 DURABILITY OF CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS OR PSORIASIS OVER THREE YEARS: AN ANALYSIS OF POOLED CLINICAL TRIAL DATA (2020) (1)
- A Case of Mixed Connective Tissue Disease Complicated by Pulmonary Hypertension and Ascites After Addition of Pulmonary Vasodilators. (2022) (1)
- 106 Effects of belimumab on corticosteroid use in a pivotal phase iii, randomised, placebo controlled study in subjects with systemic lupus erythematosus in north east asia (2017) (1)
- 110 Successful treatment of refractory lupus nephritis with secukinumab in a patient complicated with psoriasis vulgaris (2017) (1)
- A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia (2023) (1)
- THU0271 PERFORMANCE OF THE EULAR/ACR 2019 CLASSIFICATION CRITERIA FOR SYSTEMIC LUPUS ERYTHEMATOSUS IN EARLY DISEASE, ACROSS SEXES AND ETHNICITIES (2020) (1)
- Interferons and systemic lupus erythematosus: Pathogenesis, clinical features and treatments in interferon-driven disease. (2022) (1)
- Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα NANOBODY® compound, in patients with rheumatoid arthritis: 52-week results from the OHZORA and NATSUZORA trials (2023) (1)
- OP0307 Inhibitory Effects of IL-17 on Chondrogenic Differentiation of Human Mesenchymal Stem Cells Through the Phosphorylation of Sox9 (2013) (1)
- FRI0383 Safety, Pharmacokinetics, and Pharmacodynamics of Epratuzumab in Japanese Patients with Moderate-To-Severe Systemic Lupus Erythematosus: Results from A Phase 1/2 Study (2014) (1)
- FRI0251 Comparison of lipid profile including high molecular weight adiponectin (HMW-AN) after treatment with three different biologics in the patients with bio-naïve rheumatoid arthritis (RA) (2013) (1)
- SAT0088 Anti-JAK Is Anti-Fibrotic in Patients with Rheumatoid Arthritis (2016) (1)
- Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. (2022) (1)
- Efficacy of combination of Ezetimibe 10 mg and rosuvastatin 2.5 mg versus rosuvastatin 5 mg monotherapy for hypercholesterolemia in patients with type 2 diabetes (2013) (1)
- Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren's Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopat (2022) (1)
- Development of Targeted Therapies in IgG4-Related Disease. (2022) (1)
- Allogeneic Stem Cell Transplantation for Trisomy 8-Positive Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Disease with Refractory Behçet's Disease, Case Report and the Review of Literature. (2022) (1)
- FRI0280 Impact of Disease Duration before Starting Adalimumab Treatment on Work Productivity in Japanese Patients with Rheumatoid Arthritis; Analysis of 24-Weeks Data from the Anouveau Study (2014) (1)
- Long-term Safety and Efficacy of E6011, an Anti-fractalkine Monoclonal Antibody, in Patients with Rheumatoid Arthritis Inadequately Responding to Methotrexate. (2023) (1)
- Integrated Safety Analysis of Filgotinib Treatment for Rheumatoid Arthritis in Patients from Japan Over a Median of 1.5 Years. (2022) (1)
- Usefulness of Ultrasound as a Predictor of Elderly-Onset Rheumatoid Arthritis with Polymyalgia Rheumatica-Like Onset. (2022) (1)
- Long-term Evaluation of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients with Rheumatoid Arthritis Inadequately Responding to Biological Disease-modifying Antirheumatic Drugs. (2023) (1)
- Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update (2022) (1)
- FRI0201 Immunogenicity of certolizumab pegol without concomitant methotrexate and clinical response in rheumatoid arthritis patients: post-hoc analysis of the hikari study (2013) (1)
- IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis (2022) (1)
- FRI0197 Golimumab monotherapy in patients with active rheumatoid arthritis despite dmard therapy: week 104 results of clinical, radiographic and safety assessments including evaluation of remission using the new acr/eular criteria (2013) (1)
- A new and sensitive tool for autonomic dysfuntion: analysis by radiolabelled meta-iodobenzylguanidine (MIBG) in patients with familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- P133 Filgotinib in patients with RA with inadequate response to methotrexate: FINCH 1 52-week efficacy and patient reported outcomes data (2021) (0)
- Erratum to: Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (2012) (0)
- Letters to the editor (1996) (0)
- [Clinical significance of cytokine and cytokine receptor analysis in collagen diseases]. (2003) (0)
- Association between ultrasound images and patient-reported outcomes in the treatment of rheumatoid arthritis: a retrospective study (2021) (0)
- SLE and other connective tissue diseases (animal models) (WS-017) Chairpersons: Takayuki Sumida, Sachiko Hirose (2010) (0)
- Neuropsychiatric systemic lupus erythematosus detected using extravascular spillage signal on dynamic magnetic resonance imaging (Ktrans). (2021) (0)
- O4 Baricitinib-induced changes in STAT-associated gene expression in systemic lupus erythematosus (2020) (0)
- [Active arthritis due to cryoglobulinemia based on HCV infection in a patient with RA improvement of arthritis with IFN-alpha]. (2004) (0)
- Molecule-1 Induction Adhesion Via Very Late Antigen-4 Activation and Vascular Cell Adhesion Functional Cooperation of Cyclin C and c-Myc in Mediating Homotypic Cell (2010) (0)
- A Case of Type 2 Diabetes Mellitus with Large Abscesses in the Paravertebral, Iliopsoas and Gluteus Muscles Associated with Pyogenic Sacroiliitis and Pubic Bone Destruction (2015) (0)
- FRI0134 A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO DMARDS (2019) (0)
- [Effect of metformin in elderly type 2 diabetes]. (2013) (0)
- THU0243 ROLE OF METHIONINE AND ITS TRANSPORTER CD98 IN HUMAN B CELL DIFFERENTIATION AND THE RELEVANCE TO PATHOLOGICAL PROCESSES OF SLE (2019) (0)
- Use of mesenchymal stem cells seeded on the scaffold in articular cartilage repair (2018) (0)
- Detection of reverse flow by duplex ultrasonography in orthostatic hypotenssion in familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- [Biochemical markers of bone turnover. New aspect. Therapy of rheumatoid arthritis for bone metabolic marker]. (2009) (0)
- 9th International Symposium on Resistance Arteries (ISRA) (2009) (0)
- Baricitinib: Early Vs. delayed start in patients with Rheumatoid Arthritis (2018) (0)
- SP0035 PRECISION MEDICINE IN PSA (2019) (0)
- POS0653 IMPACT OF UPADACITINIB OR ADALIMUMAB AS INITIAL THERAPY ON THE ACHIEVEMENT OF 48-WEEK TREATMENT GOALS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE TO METHOTREXATE: POST HOC ANALYSIS OF A PHASE 3 STUDY (2021) (0)
- Efficacy and Safety of High-Dose of Mycophenolate Mofetil Compared With Cyclophosphamide Pulse Therapy as Induction Therapy in Japanese Patients with Proliferative Lupus Nephritis. (2021) (0)
- Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head (2017) (0)
- A refractory case of a male patient with neuropsychiatric systemic lupus erythematosus with various psychiatric symptoms and MRI observations (2020) (0)
- Scientific innovation by biologics in inflammatory immune diseases (2008) (0)
- Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: A retrospective study (2021) (0)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (2007) (0)
- Crosstalking between chemokines and adhesion molecules in the pathogenesis of rheumatoid arthritis. (2000) (0)
- [Progress in therapy and diagnosis: Hypercalcemia due to parathyroid hormone-related protein producing neoplasms]. (2007) (0)
- Revolution of treatment with biologics and management of tuberculosis in patients with rheumatoid arthritis (2010) (0)
- Combined Pioglitazone and Sulfonylurea Increase Serum Adiponectin and Lower Serum Macrophage Chemoattractant Protein-1 Concentrations in Patients with Type 2 Diabetes Mellitus (2005) (0)
- 3. State-of-the-art Internal Medicine in Joints and Bone (2019) (0)
- O25 Efficacy of anifrolumab in active systemic lupus erythematosus (SLE): patient subgroup analysis of BICLA response in 2 phase 3 trials (2020) (0)
- CNS Lupus Presenting Memory Disturbance and the PQRST Method for Memory Training (2000) (0)
- FRI0621 ASSOCIATIONS BETWEEN ORGAN INVOLVEMENTS AND GENDER, ALLERGY, AND MALIGNANCY IN 166 PATIENTS WITH IGG4-RELATED DISEASE (2019) (0)
- [Immunosuppressive effects of glucocoriticoid]. (2008) (0)
- [HIV-associated nephropathy with amoebic enteritis: a case report and literature review]. (2014) (0)
- Improved Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Failed Adalimumab or Placebo Treatment and Were Rescued with Baricitinib (2017) (0)
- Pentacyclic triterpenoid ursolic acid induces apoptosis with mitochondrial dysfunction in adult T-cell leukemia MT-4 cells to promote surrounding cell growth (2022) (0)
- Dose-Response Effects Of Denosumab, a Novel Subcutaneous RANKL Inhibitor, On The Progression Of Bone Erosion In Japanese Patients With Rheumatoid Arthritis Treated With Methotrexate : Results Of Phase II DRIVE Study-A Twelve Month Placebo Controlled, Randomized, Double Blind Study (2013) (0)
- Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis (2016) (0)
- Patterns of large-vessel lesions are associated with treatment outcomes in large-vessel giant cell arteritis (2021) (0)
- A pooled analysis of serious infections and herpes zoster-related disease in Asian patients with rheumatoid arthritis treated with peficitinib (ASP015K) over a median of 3 years. (2021) (0)
- B Cell Targeting Therapy Using the anti‐CD20 Antibody in Autoimmune Diseases (2009) (0)
- Response to: ‘Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al’ by Berkhout et al (2019) (0)
- Instructions for use Title Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients withrheumatoid arthritis (2017) (0)
- Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials (2022) (0)
- Up-Regulation on Rheumatoid Synovial Cells CD44 Is the Physiological Trigger of Fas (2001) (0)
- Risk factors for lung involvements in patients with Sjögren's syndrome (2017) (0)
- HIKARI trial of certolizumab pegol 557 (2018) (0)
- P1-01-04: Immunological Effects of Bisphosphonates on gdT Cells in Breast Cancer. (2011) (0)
- Role of nanc nerves in the gastrointestinal function inpatients with familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- [Drug-induced osteoporosis]. (2007) (0)
- Thematic stream: inflammatory arthritis (PP01–PP31)PP01. Autoinflammatory Synovitis in Familial Mediterranean Fever is Characterized by Numerous Neutrophils Lacking Myeloperoxidase and Lysozyme, Macrophages, Mast Cells and B Cells, Up-Regulation of Galectin-1, P65 (REL A)/NF-ΚB and Inos, but not COX (2011) (0)
- Efficacy and Safety of High-Dose of Mycophenolate Mofetil Compared With Cyclophosphamide Pulse Therapy as Induction Therapy in Japanese Patients with Proliferative Lupus Nephritis. (2021) (0)
- [A case of postural orthostatic tachycardia syndrome (POTS) with difficulties in differentiation from hypoglycemic attack]. (2012) (0)
- FRI0177 THE ADDITIVE EFFECTS OF HYDROXYCHLOROQUINE TO MAINTENANCE THERAPY WITH STANDARD OF CARE IN PATIENTS WITH SYSTEMIC LUPUS: ERYTHEMATOSUS (2019) (0)
- Discovery of a novel Igβ and FcγRIIB cross-linking antibody, ASP2713, and its potential application in the treatment of systemic lupus erythematosus. (2021) (0)
- FRI0099 PREDICTIVE FACTORS FOR REMISSION ACHIEVEMENT BY TOCILIZUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER INADEQUATE RESPONSE TO METHOTREXATE: A POST HOC ANALYSIS OF THE SURPRISE STUDY (2019) (0)
- [Updates on Lifestyle-Related Diseases and Bone Metabolism. Bisphosphonates for lifestyle-related disease]. (2014) (0)
- SAT0165 PERSPECTIVES OF WOMEN WITH CHRONIC RHEUMATIC DISEASES ON THEIR JOURNEY TO MOTHERHOOD: COMPARISON OF SURVEYS FROM ASIA-PACIFIC AND EUROPE (2019) (0)
- OP0199 Amplification of IL-21 Signaling Pathway Through Bruton’s Tyrosine Kinase (BTK) in Human B Cells (2013) (0)
- Intestinal Stoma for a Patient with Familial Amyloidotic Polyneuropathy Showing Severe Diarrhea (1995) (0)
- 105 Toll-like receptor 7-, but not toll-like receptor 9-, mediated interferon-Α production from plasmacytoid dendritic cells in patients with systemic lupus erythematosus (2017) (0)
- [Cyclosporin for the treatment of systemic autoimmune diseases]. (2005) (0)
- [Migration of cells in allergic inflammation]. (2003) (0)
- Cytokine-mediated signals as targets for treatment of rheumatoid arthritis: a JAK inhibitor in vitro and in vivo (2011) (0)
- Role of JAKs in myeloid cells and autoimmune diseases (2013) (0)
- Case of autoimmune polyendocrine syndrome type 3 complicated with anti‐N‐methyl‐D‐aspartic acid‐receptor encephalitis (2020) (0)
- 10 of Concomitant Disease-modifying Antirheumatic Drugs Combination Therapy in Japanese Patients with Rheumatoid Arthritis : Effect Safety and Effectiveness of 6 Months ' Etanercept Monotherapy and Yoshinaga and Michio Suzukawa (2013) (0)
- Efficacy of baricitinib in patients with rheumatoid arthritis with three years of treatment: Results from a long-term study (2020) (0)
- Risk Factors for Hypoglycemic Coma: A Study of 33 Patients on Insulin Therapy Who Were Transported to the Hospital by Ambulance (2018) (0)
- A Case of AA Amyloidosis Associated with Rheumatoid Arthritis Successfully Treated with Anti IL-6 Receptor Antibody Tocilizumab. (2010) (0)
- [Recent progress of pathogenesis and treatments in rheumatoid arthritis]. (2005) (0)
- THU0191 UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-MONOTHERAPY STUDY (2019) (0)
- Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group: an observational study (2020) (0)
- [The cutting-edge of medicine: paradigm shift of diagnosis and treatment of rheumatoid arthritis]. (2011) (0)
- [Neuropsychiatric Systemic Lupus Erythematosus]. (2019) (0)
- [Progress in the treatment targeting intracellular signaling in the context of osteoimmunology]. (2012) (0)
- [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Change in immune phenotype by the treatment of rheumatoid arthritis.] (2018) (0)
- Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan (2020) (0)
- [Treatment of rheumatic diseases: current status and future prospective. Topics: III. Biological drugs; 5. B cell targeting biologics for rheumatic diseases]. (2011) (0)
- THU0148 Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancies in Japanese Patients across the Rheumatoid Arthritis Clinical Programme (2014) (0)
- [Case of pulmonary infection with Mycobacterium chelonae in healthy breast-feeding woman]. (2007) (0)
- AB0448 SAFETY AND EFFICACY OF FILGOTINIB IN JAPANESE PATIENTS ENROLLED IN A GLOBAL PHASE 3 TRIAL OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DMARDS (2019) (0)
- Fulminant Type 1 Diabetes with Diversity in Peripheral Blood Lymphocytes: A Case Report. (2020) (0)
- [Recent Perspectives for Targeted Therapies]. (2021) (0)
- Indication for nateglinide in type 2 diabetes mellitus. (2005) (0)
- Usefulness of nailfold videocapillaroscopy for systemic sclerosis (2016) (0)
- Response to Dr Minota's Letter to the Editor of Modern Rheumatology Regarding a Study of Tofacitinib in Japanese Patients with Rheumatoid Arthritis (2016) (0)
- Relationship Between Blood Glucose Variability in Ambulatory Glucose Profile and Standardized Continuous Glucose Monitoring Metrics; A Pilot Study (2020) (0)
- THU0192 UPADACITINIB TREATMENT AND THE ROUTINE ASSESSMENT OF PATIENT INDEX DATA 3 (RAPID3) AMONG PATIENTS WITH RHEUMATOID ARTHRITIS (2020) (0)
- Biological preparation and the clinic of collagen disease With the aim of the breakthrough of the treatment. (2005) (0)
- [Generalized erythema triggered by a rapid decrease of basophils in chronic myeloid leukemia treated with imatinib]. (2005) (0)
- Signaling through adhesion molecules in inflammatory processes. (1999) (0)
- [Efficacy of new biologics on bone destruction in rheumatoid arthritis]. (2009) (0)
- OP0026 A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEFICITINIB (ASP015K) IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAD AN INADEQUATE RESPONSE TO METHOTREXATE (2019) (0)
- [B lymphocyte surface membrane immunoglobulin]. (2010) (0)
- Consistent Inhibition of Joint Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis : Pooled Analysis of Phase 2 and 3 Studies (2017) (0)
- Chemokines in Autoimmune Diseases (2004) (0)
- Lung transplantation resulted in marked improvement of autoimmunity and scleroderma in diffuse cutaneous systemic sclerosis: a case report. (2020) (0)
- OP0196 IMBALANCE BETWEEN MEMORY TH1 AND TH1-TREG CELLS DEPENDS ON DIFFERENTIAL REGULATION OF CELL METABOLISM IN PATIENTS WITH SLE (2019) (0)
- [Diabetes mellitus related common medical disorders: recent progress in diagnosis and treatment topics: I. Pathophysiology, diagnosis and treatment; 12. Osteoporosis]. (2013) (0)
- Degradation of isomerized type II collagen – A highly specific marker for joint destruction that can distinguish between different rheumatic pathologies (2016) (0)
- Synergistic Transactivation of the Sis- Inducible Element by STAT4/STAT3 Heterodimer in Cytokine Signal Cascade. (2006) (0)
- AB0132 THE STUDY OF SUBCLINICAL SYNOVITIS DETECTED BY ULTRASONOGRAPHY AND MRI IN RA PATIENTS AFTER REACHING CLINICAL REMISSION ON PATIENT’S SUBJECTIVE SYMPTOMS (2021) (0)
- [MIP-1alpha, MIP-1beta]. (2010) (0)
- Signal transduction inhibitors for the treatment of rheumatoid arthritis (2012) (0)
- Therapy of inflammatory immune diseases. 5) Anti-CD20 therapy for inflammatory immune disease (2006) (0)
- FRI0246 CELLULAR/FIBROCELLULAR CRESCENT IS A 52-WEEK AND LONG-TERM POOR PROGNOSTIC FACTOR OF ACTIVE LUPUS NEPHRITIS (2019) (0)
- Regulation of T Cell Adhesion with T Cell Differentiation and with Acute Activation by Mip-lβ Cytokine Immobilized on CD44 Proteoglycan (1993) (0)
- Constitutive Activation of Toll like Receptor Signaling in Adult T-Cell Leukemia Cells. (2006) (0)
- [Prevention and treatment of glucocorticoid-induced osteoporosis]. (2003) (0)
- Acro‐Osteolysis and Symphalangism Mutations (2005) (0)
- Paradigm shift of the treatment of rheumatoid arthritis by TNF-targeting biologics (LL3-4a)Chairperson: Tsuneyo Mimori (2010) (0)
- [Short-term Glucose Lowering Effects of Sodium-glucose Cotransporter 2 Inhibitors Confirmed by Flash Glucose Monitoring in Two Outpatients with Type 1 Diabetes]. (2020) (0)
- Eplerenone Improves Vascular Endothelial Function in Patients with Primary Aldosteronism: A Pilot Study. (2021) (0)
- [Biological preparations and clinical management of collagen diseases--for a breakthrough in therapy]. (2005) (0)
- [CD20 antibody for treatment of rheumatoid arthritis]. (2005) (0)
- Genome-oriented treatment strategies for autoimmune diseases (2021) (0)
- rheumatoid arthritis infliximab in 5000 Japanese patients with Postmarketing surveillance of the safety profile of (2008) (0)
- Dendritic cells: function 2 (WS-024b) Chairpersons: Tsuneyasu Kaisho, Christian Kurts (2010) (0)
- Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor (2020) (0)
- 3) The Front Line of Treatments for Autoimmune Diseases (2020) (0)
- A Case of Acromegaly in which a Pituitary Gland Tumor was Reduced Significantly by Administering Octreotide Long Acting Release (LAR) and Could Be Removed Surgically. (2017) (0)
- Proadhesive Cytokine Immobilized on Endothelial Proteoglycan (1994) (0)
- New clinical scale of patients with familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- Chemokine and clinical medicine. Attractiveness in clinical research of chemokine. (1997) (0)
- [Adhesion molecules in the context with bone remodeling and osteoporosis]. (2004) (0)
- [Programs for continuing medical education: A session; 8. Practice of rheumatoid arthritis]. (2012) (0)
- of Integrins and c-Met and Activation of Integrins Colon Cancer Cell Lines to Endothelial Cells by Up-Regulation CD 44 Stimulation Induces Integrin-mediated Adhesion of Updated (1999) (0)
- [Progress in B-cell targeting therapy for the treatment of systemic lupus erythematosus]. (2011) (0)
- AB0586 104-weeks assessments of clinical and structural remission in rheumatoid arthritis patients with tocilizumab from the reaction study (2013) (0)
- Differential Diagnosis of Rheumatoid Arthritis. (2010) (0)
- Response to: ‘Tocilizumab in patients with adult-onset Still’s disease refractory to glucocorticoid treatment’ by Lee (2018) (0)
- SAT0008 IL-23 DRIVES PATHOGENIC TH17 CELLS THROUGH EPIGENETIC REGULATION BY STAT3 IN SLE PATIENTS (2019) (0)
- Su1862 POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS (2020) (0)
- Differentiation, functions, and roles of T follicular regulatory cells in autoimmune diseases (2021) (0)
- Predicting Disease Activity for Biologic Selection in Rheumatoid Arthritis (2020) (0)
- THU0159 A Large-Scale Prospective Single Cohort Observational Study of Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis Receiving Adalimumab: The Final Analysis of 48-Week Data from The Anouveau Study (2016) (0)
- P111 Exploratory Analysis of Filgotinib Safety Data in Patients With Moderately to Severely Active Rheumatoid arthritis and an Increased Risk of Cardiovascular Events: Data From Phase 2 and 3 Clinical Trials (2023) (0)
- Expression of the Chk2 Gene Is Downregulated in Hodgkin’s Lymphoma Cell Lines Via Epigenetic Mechanisms. (2004) (0)
- FRI0095 Diversity of The Peripheral Immunological Phenotype after Biologic DMARD Therapy in Patients with Rheumatoid Arthritis (2016) (0)
- Epstein–Barr virus-induced gene 3 commits human mesenchymal stem cells to differentiate into chondrocytes via endoplasmic reticulum stress sensor (2022) (0)
- Efficacy of once-weekly teriparatide for primary prevention of glucocorticoid-induced osteoporosis: A post hoc analysis of the TOWER-GO study. (2021) (0)
- THU0167 Neo-Epitopes of Connective Tissue Turnover are Biomarkers of Disease Activity and Modulated in Response to Tofacitinib or Tocilizumab in Rheumatoid Arthritis (2015) (0)
- Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis (2023) (0)
- Benefits of targeting TNF—α in the treatment of RA (2004) (0)
- Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis (2016) (0)
- Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study (2022) (0)
- 3．State-of-the-art Internal Medicine in Joints and Bone (2019) (0)
- [Molecular targeted therapy]. (2014) (0)
- Correction: Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (2023) (0)
- Contents Vol. 46, 2009 (2009) (0)
- Clinical features of polymyalgia rheumatica patients in Japan: Analysis of real-world data from 2015 to 2020. (2023) (0)
- THU0210 Malignancy Data in Tofacitinib-Treated Japanese Patients with Rheumatoid Arthritis (2016) (0)
- FRI0231 Study on the safety and efficacy of infliximab (IFX), an anti-TNF-α antibody, in patients with refractory intestinal-behÇet’s disease (BD) (2013) (0)
- The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study (2023) (0)
- Genome-oriented treatment strategies for autoimmune diseases (2021) (0)
- 1731-P: The Involvement of Glutaminolysis in ß-Cell Differentiation and Its Clinical Application for Type 1 Diabetes (2019) (0)
- THU0149 A clinical and pathological characterization of methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis (2017) (0)
- TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus. (2022) (0)
- 30 Metabolic reprogramming in cd4+cd28-cxcr3intt-bethi cells and its relevance to pathogenesis in patients with sle (2017) (0)
- FRI0170 The Comparative Effectiveness of Five Biologics as Second-Line Use for Patients with Rheumatoid Arthritis in Daily Clinical Practice (2015) (0)
- THU0219 THE INVOLVEMENT OF MITOCHONDRIAL ACTIVATION VIA GLUTAMINOLYSIS IN HUMAN B CELL DIFFERENTIATION AND ITS RELEVANCE TO THE PATHOGENESIS OF SLE (2019) (0)
- Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data (2023) (0)
- Association Between Time in Range and HbA1c in Japanese Patients With Type 2 Diabetes Mellitus (2021) (0)
- Perspectives on current and emerging therapies for IgG4-related disease. (2022) (0)
- A Case of Simultaneous Onset of Highly Active Systemic Lupus Erythematosus and IgG4-Related Renal Disease. (2022) (0)
- Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2). (2021) (0)
- Illustrations of rheumatoid arthritis symptoms to promote communications between patients and physicians. (2022) (0)
- [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: V. Evaluation; 2. Evaluation of joint destruction by plain X-ray in rheumatoid arthritis]. (2012) (0)
- Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis. (2023) (0)
- Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study (2022) (0)
- Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis (0)
- Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression (2022) (0)
- CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES (2021) (0)
- [Diabetic vascular calcification and abnormal bone metabolism: the relation between bone and vascular]. (2006) (0)
- OP0027 Abnormal B Cell Activation through Cellular Metabolic Reprogramming and Its Relevance To The Pathogenesis of SLE (2016) (0)
- [Glucocorticoid-induced abnormality in bone remodeling.] (2017) (0)
- Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study (2018) (0)
- Arthritis Mediated by P-glycoprotein on Lymphocytes in Refractory Rheumatoid Tacrolimus , a Calcineurin Inhibitor , Overcomes Treatment Unresponsiveness (2010) (0)
- OA06 Clinical outcomes of filgotinib in patients with rheumatoid arthritis aged ≥65 years: a post hoc subgroup analysis of Phase 2 and 3 clinical trials and ongoing long-term extensions (2023) (0)
- FRI0031 Dna oxidase enzyme tet3 exacerbates synovial inflammation and bone destruction (2017) (0)
- Bindings of mutant transthyretin with high density lipoprotein (HDL) and low density lipoprotein (LDL): a novelfunction of lipoprotein (1996) (0)
- POS0877 THE EFFECT OF PLATELET INHIBITORS ON DIGITAL ULCERS IN SYSTEMIC SCLEROSIS - A DERIVATION AND VALIDATION EUSTAR STUDY (2021) (0)
- 3) Recent Progress in Cytokine-targeting Therapies in Rheumatic Diseases (2019) (0)
- State-of-the art treatment strategy for rheumatic diseases (2019) (0)
- [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. (2004) (0)
- AB0513 Treatment Strategy Targeting Structural Remission in Patients with Early Rheumatoid Arthritis: A Multi-Central, Prospective, Comparative Study Targeting Joint Damage to Zero (Zero-J Study) (2015) (0)
- Autocrine Stimulation of Inter leu kin la in the Growth of Adult Human T-Cell Leukemia Cells1 (2006) (0)
- AB0415 A New Prognostic Factor to Sustain Remission for 2 Years after Adalimumab Discontinuation & the Clinical Outcomes in RA Patients: Honor Study 2-Years Results (2014) (0)
- Rituximab in the Real-World Treatment of Lupus Nephritis: A Retrospective Cohort Study in Japan. (2022) (0)
- THU0187 Serum 14-3-3ETA is a Modifiable, Mechanistic Biomarker that Predicts Tocilizumab Response (2015) (0)
- Association between the patterns of large-vessel lesions and treatment outcomes in patients with large-vessel giant cell arteritis. (2022) (0)
- Treatment of lupus nephritis: consensus, evidence and perspectives (2023) (0)
- IN VITRO ANTIBACTERIAL ACTIVITIES OF METHANOL AND AQUEOUS EXTRACTS OF LEAVES OF LEPIDIUM SATIVUM, AZADIRACHTA INDICA AND MORINGA OLEIFERA AGAINST SELECTED PATHOGENIC BACTERIA (2020) (0)
- Recurrent Ischemic Colitis: Analysis of Factors for Recurrence (1995) (0)
- O09 Pooled safety analyses from Phase 3 studies of filgotinib in patients with RA (2020) (0)
- Corrigendum to: Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort (2022) (0)
- AB0294 Long-term comprehensive disease control with certolizumab pegol regardless of concomitant dmards: results from the japanese cohort (2013) (0)
- OP0205 Association between t follicular helper cell and plasmablast correlates with disease activity in patients with systemic lupus erythematosus (2017) (0)
- Possible involvement of CXCR3-CXCR6 + CD4 + T cells in Langerhans cell histiocytosis (2023) (0)
- THU0191 Effects of tofacitinib, an oral janus kinase inhibitor, on patient-reported outcomes in japanese patients with rheumatoid arthritis (2017) (0)
- EFFECTS OF ANIFROLUMAB ON RENAL DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (2022) (0)
- Erratum to: Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis (2016) (0)
- Lower injection‐site reactions and long‐term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post‐hoc analysis of a double‐blind, randomized, phase III comparative study and its open‐label extension in patients with rheumatoid arthritis (2022) (0)
- Reduced homovanillic acid, SDF-1α, and SCGF-β levels in cerebrospinal fluid are related to depressive states in systemic lupus erythematosus. (2023) (0)
- 409 Disease severity and burden in japanese patients with systemic lupus erythematosus from claims database (2017) (0)
- Subcutaneous injection of methotrexate: advantages in the treatment of rheumatoid arthritis. (2022) (0)
- Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials (2022) (0)
- POS0028 DEFINING THE PREVALENCE OF UNMET NEED IN SLE: DATA FROM A LARGE MULTINATIONAL LONGITUDINAL SLE COHORT (2021) (0)
- Paradigm Shift of Diagnosis and Treatment of Rheumatoid Arthritis. (2011) (0)
- Evaluation of asymptomatic cerebral ischemia by arterial spin-labeling magnetic resonance imaging of the brain in Takayasu arteritis. (2022) (0)
- THU0231 IL-2 DRIVES THE CONVERSION OF T FOLLICULAR HELPER TO T FOLLICULAR REGULATORY CELLS THROUGH EPIGENETIC MODIFICATION IN SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
- A Comparative Study on the Efficacy and Safety of Dose Escalation of Luseogliflozin in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control (2023) (0)
- FRI0214 Long-term efficacy and safety of sirukumab in patients with active rheumatoid arthritis despite anti-tumor necrosis factor therapy: results of the randomized, phase 3 sirround-t study (2017) (0)
- POS0336 PATTERNS OF LARGE-VESSEL LESIONS AND POOR TREATMENT OUTCOMES IN PATIENTS WITH LARGE-VESSEL GIANT CELL ARTERITIS (2021) (0)
- OP0196 IMBALANCE BETWEEN MEMORY TH1 AND TH1-TREG CELLS DEPENDS ON DIFFERENTIAL REGULATION OF CELL METABOLISM IN PATIENTS WITH SLE (2019) (0)
- [Targeting CD20 in rheumatoid arthritis]. (2007) (0)
- Enlarged perivascular spaces are associated with the disease activity in systemic lupus erythematosus (2017) (0)
- FRI0012 Pronounced SYK phosphorylation and TRAF6 overexpression in B cells correlating with the activity of systemic lupus erythematosus (2013) (0)
- Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus (2018) (0)
- Haemoglobin changes and disease activity in Japanese patients with rheumatoid arthritis treated with sarilumab. (2021) (0)
- Long-Term Safety and Efficacy of Filgotinib Treatment for Rheumatoid Arthritis in Japanese Patients Naïve to MTX Treatment (FINCH 3). (2022) (0)
- Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis (2022) (0)
- FRI0096 Predictive Value of The Multi-Biomarker Disease Activity (MBDA) Score for Flare and Sustained Remission in The Honor Study (2016) (0)
- FRI0190 CDAI is a predictor of physical function and bone destruction at week 52 in RA patients (2013) (0)
- 30 Metabolic reprogramming in cd4+cd28-cxcr3intt-bethi cells and its relevance to pathogenesis in patients with sle (2017) (0)
- Systemic lupus erythematosus. (2023) (0)
- A case of glucocorticoid-resistant adult Still's disease complicated by pulmonary hypertension and interstitial lung disease. (2022) (0)
- [Assessment of joint structure in patients with rheumatoid arthritis]. (2013) (0)
- Light chain proximal tubulopathy after improvement of tubulointerstitial nephritis in Sjögren's syndrome (2022) (0)
- SAT0193 A PHASE 3, OPEN-LABEL, CONTINUATION STUDY EVALUATING LONG-TERM SAFETY AND EFFICACY OF BELIMUMAB IN PATIENTS FROM JAPAN AND KOREA WITH SYSTEMIC LUPUS ERYTHEMATOSUS, FOR UP TO 7 YEARS (2020) (0)
- Reply to Dr Pollono (2008) (0)
- FRI0251 SIRUKUMAB, an ANTI-IL-6 cytokine monoclonal antibody, leads to improvements in work productivity and general health status in patients with active rheumatoid arthritis refractory to ANTI-TNF therapy: results from the phase 3 SIRROUND-T study (2017) (0)
- FRI0102 SERUM TNFΑ LEVELS AT 24 HOURS AFTER FIRST ADMINISTRATION OF CERTOLIZUMAB PEGOL PREDICT EFFECTIVENESS AT WEEK 12 IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM TSUBAME STUDY (UMIN ID:0002381) (2020) (0)
- Correction: IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis (2022) (0)
- A case of giant cell arteritis complicated by polymyalgia rheumatica with scalp necrosis and refractory jaw claudication. (2022) (0)
- Short-Term Prognostic Factors in Hospitalized Herpes Zoster Patients and Its Associated Cerebro-Cardiovascular Events: A Nationwide Retrospective Cohort in Japan (2022) (0)
- Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study (2023) (0)
- Computed tomography for malignancy screening in patients with rheumatoid arthritis before initiation of disease modifying antirheumatic drug. (2023) (0)
- AB0546 Clinical and functional remission based on newly defined ACR/EULAR remission criteria achieved with tocilizumab in patients with rheumatoid arthritis (2013) (0)
- Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison (2023) (0)
- SAT0062 14-3-3ETA predicts joint damage progression and flaring after adalimumab discontinuation (2017) (0)
- Changes in Glucose Intolerance after Treatment with Antithyroid Drugs in Patients with Graves' Disease Using Continuous Glucose Monitoring: A Pilot Study. (2022) (0)
- Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes (2023) (0)
- Severe skin ulceration associated with Wegener’s granulomatosis: successful treatment with hyperbaric oxygen and prostaglandin E1 (2003) (0)
- SAT0012 A Multi-Biomarker Disease Activity (VECTRA™ DA Algorithm) Score is Associated with Radiographic Outcomes in RA Patients Treated with TNF Inhibitors (2013) (0)
- 3. Hypercalcemia due to Parathyroid Hormone-related Protein Producing Neoplasms (2007) (0)
- Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance. (2021) (0)
- Belimumab: A BAFF-specific Inhibitor for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis (2022) (0)
- THU0231 IL-2 DRIVES THE CONVERSION OF T FOLLICULAR HELPER TO T FOLLICULAR REGULATORY CELLS THROUGH EPIGENETIC MODIFICATION IN SYSTEMIC LUPUS ERYTHEMATOSUS (2020) (0)
- Opportunistic infections and countermeasure in connective tissue diseases. (2004) (0)
- SAT0152 EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS WITH 3 YEARS OF TREATMENT: RESULTS FROM A LONG-TERM STUDY (2020) (0)
- What are the hot topics in Japanese rheumatology? Go above and beyond (2023) (0)
- [Transplantation and osteoporosis]. (2007) (0)
- Post hoc Analysis of Clinical Characteristics of Patients with Radiographic Progression in a Japanese phase 3 trial of Peficitinib and Methotrexate Treatment (RAJ4). (2022) (0)
- Safety and Efficacy of Filgotinib for Japanese Patients with RA and Inadequate Response to MTX: FINCH 1 52-Week Results and FINCH 4 48-Week Results. (2022) (0)
- [A case of alcoholic liver cirrhosis with pyogenic spondlitis and iliopsoas abscess]. (2006) (0)
- Efficacy and tolerability of subcutaneously administered methotrexate including dose escalation in long-term treatment of rheumatoid arthritis in a Japanese population. (2022) (0)
- [A Case of Reactive Hypoglycemia Exacerbated Before Menstruation Improved by the Use of Continuous Glucose Monitoring]. (2022) (0)
- 1401 Effects of anifrolumab on renal disease in patients with systemic lupus erythematosus (2021) (0)
- Rituximab in Remission Induction and Maintenance Therapy for Microscopic Polyangiitis Associated with Gastric Cancer: A Case Report. (2021) (0)
- THU0145 A multi-biomarker disease activity (MBDA) score measures rheumatoid arthritis disease activity in patients treated with the JAK inhibitor tofacitinib (2013) (0)
- Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD. (2022) (0)
- FRI0285 Initial Adalimumab plus Methotrexate Treatment Prevents Joint Destruction Irrespective of Treatment Duration in Japanese Patients with Early Rheumatoid Arthritis: Post-Hoc Analysis of HOPEFUL 1 and 2 Studies (2014) (0)
- aaneo - ucmg cytokines to leukocytes (1993) (0)
- FRI0097 Baseline Serum 14-3-3 ETA Independently Predicts Clinically Important Improvements in HAQ-DI in Patients with Rheumatoid Arthritis Treated with Tocilizumab (2016) (0)
- FRI0055 Ectopic calcification is mediated by inflammatory cytokines enhancing differentiation of adipose-derived stem cells into osteoblasts (2013) (0)
- Down-Regulated Th17 Cells in a Patient With Familial Mediterranean Fever Associated with AA Amyloidosis in the Treatment of Canakinumab. (2022) (0)
- Impact of initial therapy with upadacitinib or adalimumab on achievement of 48-week treatment goals in patients with rheumatoid arthritis: post hoc analysis of SELECT-COMPARE (2022) (0)
- SAT0104 MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+ PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY (2020) (0)
- Induces Apoptosis of Human Mast Cells Leflunomide Inhibits PDK1/Akt Pathway and (2007) (0)
- Intracellular HMGB1 Transactivates the Human IL1B Gene Promoter through Association with an ETS Transcription Factor PU.1. (2006) (0)
- OP0162 Toll-like Receptor 7-, but Not Toll-like Receptor 9-, Mediated Interferon-α Production from Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus (2016) (0)
- THU0114 CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS: POOLED EFFICACY ANALYSIS OF PHASE 3 CLINICAL TRIALS ACROSS BASELINE RHEUMATOID FACTOR QUARTILES (2020) (0)
- BAFF- and APRIL-targeted therapy in systemic autoimmune diseases (2016) (0)
- Low Vitamin D Levels are Associated with Vascular Endothelial Dysfunction in Patients with Type 2 Diabetes: A Retrospective Study (2020) (0)
- Remission of Granulomatosis with Polyangiitis Only After Resection of a Pulmonary Nodule (2022) (0)
- The management of women of child-bearing age with rheumatoid arthritis: an expert report. (2023) (0)
- Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies (2023) (0)
- THU0243 ROLE OF METHIONINE AND ITS TRANSPORTER CD98 IN HUMAN B CELL DIFFERENTIATION AND THE RELEVANCE TO PATHOLOGICAL PROCESSES OF SLE (2019) (0)
- 52 The pathogenic relevance of t follicular helper cells-plasmablasts axis in patients with systemic lupus erythematosus (2017) (0)
- Enhancer RNA commits osteogenesis via microRNA-3129 expression in human bone marrow-derived mesenchymal stem cells (2022) (0)
- Correction: IL-6 production through repression of UBASH3A gene via epigenetic dysregulation of super-enhancer in CD4+ T cells in rheumatoid arthritis (2022) (0)
- FRI0252 Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials (2017) (0)
- SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment (2016) (0)
- AB0486 Effect of Baseline Disease Duration on Development of Clinical Remission in the RA Patients Receiving Tocilizumab – Data from PMS with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
- FRI0202 A large-scale prospective single cohort study of work productivity and activity impairment in japanese patients with rheumatoid arthritis receiving adalimumab: analysis of 24-weeks data from the anouveau study (2013) (0)
- SAT0120 Characteristics Associated with Better Effectiveness and Safety in Rheumatoid Arthritis Patients Treated with Intravenous Tocilizumab: Results from Full Analysis of All-Patient Postmarketing Surveillance in Japan (2013) (0)
- Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-center, randomized controlled trial. (2022) (0)
- Miliary Pulmonary Cryptococcosis in IgG4-related Disease. (2022) (0)
- Visceral orthostatic hypotension in patients with familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- JAK inhibitors for rheumatoid arthritis (2023) (0)
- Anti-proliferative and anti-inflammatory activities of belinostat: Therapeutic potential for rheumatoid arthritis? (2008) (0)
- Usefulness of hemoglobin A1c and glycated albumin measurements for insulinoma screening: an observational case-control study (2019) (0)
- THU0027 Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells (2016) (0)
- Recent progress in small molecular products for the treatment of joint and bone diseases: an over view (2011) (0)
- [Homeostasis and Disorder of Musculoskeletal System.Progress in the treatment of rheumatoid arthritis.] (2018) (0)
- Successful treatment with etanercept in a case of seronegative rheumatoid arthritis with corticosteroid/methotrexate-resistant pemphigus erythematosus (2018) (0)
- POS0604 LONG TERM SAFETY AND TOLERABILITY WITH ETANERCEPT BIOSIMILAR (YLB113), RESULTS FROM A 2-YEAR OPEN LABEL EXTENSION STUDY (STUDY NO. YLB113-003) (2021) (0)
- FRI0210 Real-world hawk study: long-term safety and effectiveness of adalimumab with higher-dose methotrexate in japanese patients with early rheumatoid arthritis (2017) (0)
- O8 Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematosus in men, ethnicities, and early disease (2020) (0)
- The occurrence of hypertrophic pachymeningitis with infiltration of IgG4-positive plasma cells and with different aetiology: report of three cases (2017) (0)
- AB0412 FACTORS THAT AFFECT THE RESPONSE TO TOCILIZUMAB WITH REGARD TO WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A 2-YEAR FOLLOW-UP OF THE FIRST ACT-SC STUDY (2019) (0)
- [One case of Cronkhite-Canada syndrome, in which the course from onset to spontaneous curing could be followed]. (2004) (0)
- Management of chronic rheumatic diseases in women 18–45 years of age in Asia Pacific: insights from patient and clinician surveys (2022) (0)
- 全身性エリテマトーデス（SLE）患者B細胞におけるケモカイン受容体発現異常 (2015) (0)
- A cross-trait genetic correlation study identified eight diseases and traits associated with psoriasis. (2023) (0)
- THU0194 CHARACTERISATION OF DEPTH OF RESPONSE, INCLUDING 50% IMPROVEMENT IN ACR COMPONENTS AT WEEK 12 AND REMISSION AT WEEK 24, FOLLOWING TREATMENT WITH FILGOTINIB COMPARED WITH METHOTREXATE OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS (2020) (0)
- Role of nitric oxide in controlling peripheral blood flow of patients wtth familial amyloidotic polyneuropathy (FAP)type i (1996) (0)
- Erratum (2018) (0)
- [Case of graves' disease with remarkable psychiatric symptoms]. (2015) (0)
- P134 Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with RA: results from RA-BEYOND (2021) (0)
- Effect of liver transplantation on autonomic dysfunction in familial myloidotic polyneuropathy type i (Met30) (1996) (0)
- AB0213 THE USE OF MUSCULOSKELETAL ULTRASOUND AND PATIENT REPORTED OUTCOMES TO IDENTIFY THE FACTOR TO GIVE RESIDUAL SYMPTOMS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN SDAI-REMISSION OR LOW DISEASE ACTIVITY. (2020) (0)
- Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan (2020) (0)
- Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis (2021) (0)
- [CD20 antibody for the treatment of systemic autoimmune diseases]. (2005) (0)
- The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression. (2014) (0)
- Subject Index Vol. 46, 2009 (2009) (0)
- [Neuropsychiatric Systemic Lupus Erythematosus]. (2016) (0)
- Via c-Myc-Dependent and-Independent Very Late Antigen-4 Integrin and VCAM-1 A Novel Role for HRas in the Regulation of (1999) (0)
- 2358-PUB: Efficacy and Safety of Tofogliflozin on 24-hr Glucose Profile Based on Continuous Glucose Monitoring—Crossover Study of Sodium-Glucose Cotransporter 2 Inhibitor (2019) (0)
- Performance of the EULAR/ACR 2019 Classifi cation Criteria for Systemic Lupus Erythematosus in Men, Diverse Ethnicities, and Early Disease (2019) (0)
- [New trends in therapy for arthritis rheumatoid]. (2006) (0)
- Introducing the launch of Modern Rheumatology Case Reports (2017) (0)
- Human dendritic cell-derived osteoclasts have the ability for both bone absorption and T cell stimulation (2016) (0)
- Correction to: RANKL as a therapeutic target of rheumatoid arthritis (2020) (0)
- [Primary hypomagnesemia]. (2006) (0)
- JNK/c-Jun Is Required for HMC-1 Cell Proliferation. (2006) (0)
- Change in the age of onset in patients with familial amyloidotic polyneuropathy (FAP) type i in Japan (1996) (0)
- Highlights of the 25th Conference of the European Society for Microcirculation (2009) (0)
- Toll-like receptors, session 1 (WS-001a) Chairpersons: Kensuke Miyake, Hermann Wagner (2010) (0)
- PREPARATION PERNASALE A BASE DE threo-3-(3,4-DIHYDROXYPHENYL)SERINE (1994) (0)
- [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment; 1. Treatment strategies, 2) treat to target in rheumatoid arthritis]. (2012) (0)
- Activation of the Inflammatory Cytokine Genes by Intracellular Galectin-9 in Human Monocytes. (2007) (0)
- Comparison Between Effectiveness of 100 mg/day Sitagliptin and a Switch to Mitiglinide Calcium Hydrate/Voglibose from 50 mg/day Sitagliptin in Patients with Type 2 Diabetes. (2017) (0)
- Instructions for use Title Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis : results from alarge Japanese postmarketing surveillance study (2019) (0)
- Acetylation of an Ets Transcription Factor PU.1 Suppresses Its Transcriptional Activity. (2007) (0)
- Difficult-to-treat rheumatoid arthritis with respect to responsiveness to newly used biologic/targeted synthetic disease-modifying anti-rheumatic drug: a retrospective cohort study (2020) (0)
- Glycemic Profiling in Patients with Drug-Naïve Type 2 Diabetes by Continuous Glucose Monitoring. (2018) (0)
- Effects of oxygen therapy during sleep in chronic dialysis patients with sleep-disordered breathing (2005) (0)
- Electrophiological chanes in the spinal cord in patients with familial amyloidotic polyneuropathy (FAP) type i (1996) (0)
- 】 IgG 4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion : A Case Report (2018) (0)
- THU0199 Week 12 Clinical Response to Certolizumab Pegol Predicts Long-Term Outcomes Regardless of Concomitant Medications and Baseline Disease Characteristics in Japanese Patients with Active Rheumatoid Arthritis (2013) (0)
- THU0198 Baricitinib Effects on Lipid and NMR-Measured Lipoprotein Profiles in A Phase 3 Study in Patients with Rheumatoid Arthritis (2016) (0)
- [Anti-CD20 antibody for the treatment of systemic autoimmune diseases]. (2004) (0)
- Evaluation of autonomic disorders in familial amyloidotic polyneuropathy (FAP) (1993) (0)
- A case of acquired selective IgA deficiency with systemic lupus erythematosus: Consideration of relationship between recurrent infection and occurring of systemic autoimmune diseases in selective IgA deficiency (1994) (0)
- T Induction of Integrin-Mediated Adhesion of H-Ras Signals to Cytoskeletal Machinery in (1999) (0)
- Infections associated with systemic lupus erythematosus: Tackling two devils in the deep blue sea (2022) (0)
- Chemokine and heparan sulfate proteoglycan in the context of integrin activation. (1998) (0)
- SAT0026 IMPACT OF TOCILIZUMAB ON IMMUNE PHENOTYPES IN PATIENTS WITH LARGE VESSEL VASCULITIS (2019) (0)
- [Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis]. (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yoshiya Tanaka?
Yoshiya Tanaka is affiliated with the following schools:
